{
  "schema_version": "0.1.0",
  "case_id": "HR-ML035",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "ML035",
    "display_name": "Mahalia Jackson",
    "aliases": [
      "Mahala Jackson"
    ],
    "historical_mentions": [
      "HR-ML001"
    ],
    "sex": "female",
    "era": "Mid-Late 20th Century",
    "nationality": "American",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1911-10-26",
          "display": "October 26, 1911",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1911",
              "display": "1911",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0007"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with The New York Times."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1972-01-27",
          "display": "January 27, 1972",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1972",
              "display": "1972",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0007"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with The New York Times and the presidential statement."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-ML035-SYN",
      "ssn": "000-35-4692",
      "date_of_birth": "1973-10-26",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Beatrice Fontenot, MD",
      "fictional_consultant": {
        "name": "Kwabena Asante-Miller, MD",
        "specialty": "Pulmonology (sarcoidosis)"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1911-10-26",
        "display": "October 26, 1911",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born in New Orleans.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1928",
        "display": "1928",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Moves to Chicago and joins the Greater Salem Baptist Church.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1950-10-04",
        "display": "October 4, 1950",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Carnegie Hall debut.",
      "claim_ids": [
        "CLM-0002",
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1952",
        "display": "1952",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "First European tour, sung in pain with breathlessness, then cancelled; hysterectomy, with granulomas found and sarcoidosis diagnosed.",
      "claim_ids": [
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1963-08-28",
        "display": "August 28, 1963",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Sings at the March on Washington.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1965",
        "display": "1964 to 1965",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Admitted in Chicago after a coughing spell (month not recorded); told privately of a heart attack and sarcoidosis in her heart; a year of recovery without touring.",
      "claim_ids": [
        "CLM-0006",
        "CLM-0012"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1967",
        "display": "Fall 1967",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Hospitalized for heart trouble.",
      "claim_ids": [
        "CLM-0007"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "1968",
        "display": "1968",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Cuts short a European tour; eye inflammation and cramps in her legs and hands.",
      "claim_ids": [
        "CLM-0008"
      ]
    },
    {
      "event_id": "EVT-0009",
      "date": {
        "iso": "1971",
        "display": "1971",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Tours Japan, India and Europe; falls ill in Germany after her last concert, in Munich, and is hospitalized at home.",
      "claim_ids": [
        "CLM-0009"
      ]
    },
    {
      "event_id": "EVT-0010",
      "date": {
        "iso": "1972-01-27",
        "display": "January 27, 1972",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Dies at Little Company of Mary Hospital in Evergreen Park, Illinois, at 60.",
      "claim_ids": [
        "CLM-0010",
        "CLM-0011"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Mahalia Jackson was born in New Orleans on October 26, 1911, the third of six children of a man who was a longshoreman by day, a barber by night and a clergyman on Sunday. Her mother died when she was six, and she was raised by an aunt in a poor but respectable home; she left school in the eighth grade to work as a cook and washerwoman.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Born in New Orleans on Oct. 26, 1911, she was the third of six children; left motherless when she was 6; reared by Aunt Duke; obliged to leave school in the eighth grade to work as a cook and washerwoman"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "context",
          "locator": "roster birth date"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "In 1928 she moved to Chicago, worked as a hotel maid and laundress, and joined the Greater Salem Baptist Church, where she became a soloist. She never learned to read music. After her Carnegie Hall debut on October 4, 1950, she began touring abroad in 1952, and toured widely for the rest of her life.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Her life as a touring singer anchors the modern social history and the plan built around her performing and travel.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "In 1928, she departed New Orleans for Chicago; Greater Salem Baptist Church; never learned to read music; Oct. 4, 1950, Carnegie Hall; began her tours abroad in 1952"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "moved north to Chicago in 1927 (gives the year differently)"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "She was closely associated with the civil rights movement and sang at the March on Washington in 1963 before Dr. Martin Luther King Jr.'s speech. When she moved into an all-white neighborhood on the South Side of Chicago, a bullet was fired through a window of her home.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the modern social history: a singer whose work was bound up with the civil rights movement, who met racist violence at home.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "chosen to sing at the Rev. Dr. Martin Luther King Jr.'s March on Washington rally; a bullet was fired through a window of her home"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "Touring the segregated South for as many as 200 dates a year, she and her company had trouble finding safe places to sleep, eat and buy gas, sometimes slept in her car, lived on bags of fruit and drove half the night, and she arrived so exhausted she was almost dizzy when she sang; she insisted on being paid in cash because checks were often refused.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "Context for the modern social history; the details come from a tertiary summary of her autobiography and Goreau's biography.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "performing 200 dates a year for ten years; difficulty finding safe, clean places to sleep, eat, and buy gas due to Jim Crow laws; living on bags of fresh fruit during the day and driving half the night; contracts demanded she be paid in cash"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "picked up the technique early after discovering that many segregated Southern banks wouldn't cash a check"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "Before and during her first European tour in 1952 she had difficulty breathing during and after performances and severe abdominal cramping, sang many shows in pain, lost a great deal of weight and finally cancelled the tour. On her return she had a hysterectomy, at which numerous granulomas were found in her abdomen, and she was diagnosed with sarcoidosis. From then on she had occasional bouts of fatigue and shortness of breath that became more frequent as her schedule filled.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "The anchor for the modern presenting problem and the past history. The account rests on Goreau's biography as summarized by Wikipedia and on TheWrap; no pathology record was found.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "she began having difficulty breathing during and after performances; had a hysterectomy and doctors found numerous granulomas in her abdomen. She was diagnosed with sarcoidosis; occasional bouts of fatigue and shortness of breath"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "a hysterectomy she received after touring London and Europe; Jackson was diagnosed with sarcoidosis"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "In 1964, weeks after her marriage, she could not stop coughing on the drive home from a concert in St. Louis and admitted herself to a Chicago hospital. The diagnosis given in public was heart strain and exhaustion; her doctors told her privately that she had had a heart attack and that sarcoidosis was now in her heart. Recovery took a year, during which she could not tour or record and lost about 50 pounds; afterwards she had near-constant fatigue, bouts of tachycardia and high blood pressure. From 1964 she was in and out of hospitals, and physicians warned her of exhaustion from her itineraries.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "The documented cardiac illness to which the modern diagnosis of cardiac sarcoidosis is linked. The account of what her doctors told her privately comes from Goreau's biography as summarized by Wikipedia.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "unable to stop coughing; checked herself into a hospital in Chicago; publicly disclosed diagnosis was heart strain and exhaustion, but in private Jackson's doctors told her that she had had a heart attack and sarcoidosis was now in her heart; losing 50 pounds"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Since 1964 Miss Jackson was in and out of hospitals. Physicians warned her of exhaustion from her demanding itineraries"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "it took her a year to recover and she lost 50 pounds"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "She was hospitalized for heart trouble in the fall of 1967.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Documented heart illness after the index date.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "She was hospitalized in the fall of 1967 for heart trouble"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "By the late 1960s she had inflammation in her eyes and painful cramps in her legs and hands; she cut short a European tour in 1968 for health reasons.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "Documented symptoms after the index date; that the eye inflammation was sarcoid uveitis is not stated in the sources.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "she had to cut one tour short in 1968 due to health concerns; painful cramps in both her legs and hands, as well as inflammation in her eyes"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "Now experiencing inflammation in her eyes and painful cramps in her legs and hands"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0009",
      "statement": "In 1971 she toured Japan, India and Europe; she became ill on tour in Germany, where she gave her last concert in Munich, and was flown home to Chicago and hospitalized in the fall.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Documented final illness; history only.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Last year she toured Japan, India and Europe; hospitalized ... again last fall"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "giving her final concert in 1971 in Munich, Germany"
        },
        {
          "source_id": "SRC-0008",
          "relationship": "supports",
          "locator": "After collapsing in 1971 on tour in Munich"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "became ill in Germany and flew home to Chicago where she was hospitalized"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0010",
      "statement": "She died on January 27, 1972, at Little Company of Mary Hospital in Evergreen Park, Illinois, at 60, after several years of poor health.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The documented death. History only, stated without detail.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "died ... yesterday in Little Company of Mary Hospital in Evergreen Park, Ill.; She was 60 years old, and had been in poor health for several years"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "died after a prolonged illness at the Little Company of Mary Hospital in Evergreen Park"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0011",
      "statement": "The cause of her death is recorded differently: a heart seizure (The New York Times), heart failure (PBS), a heart attack (Biography.com), heart complications at home (New Orleans Historical), and death in recovery after surgery for a bowel obstruction, which one account attributes to sarcoidosis (Wikipedia, TheWrap).",
      "evidence_grade": "R",
      "certainty": "disputed",
      "clinical_interpretation": "Retrospective; the accounts conflict, and none gives a medical record. The modern episode does not resolve the question.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "died of a heart seizure"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "She died of heart failure"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "She died of a heart attack"
        },
        {
          "source_id": "SRC-0008",
          "relationship": "supports",
          "locator": "died early the next year of heart complications in her home in Chicago"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "received surgery to remove a bowel obstruction and died in recovery"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "died in recovery after surgery to remove a bowel obstruction caused by sarcoidosis"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0012",
      "statement": "That her heart disease, and the heart trouble that recurred until her death, was cardiac sarcoidosis is a retrospective interpretation. It rests on the private account of her doctors in 1964 reported by her biographer; the public diagnoses were heart strain, exhaustion and heart trouble.",
      "evidence_grade": "R",
      "certainty": "possible",
      "clinical_interpretation": "Retrospective interpretation linked to the modern cardiac sarcoidosis problem; it is not a confirmed historical diagnosis.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "in private Jackson's doctors told her that she had had a heart attack and sarcoidosis was now in her heart"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "context",
          "locator": "hospitalized in the fall of 1967 for heart trouble"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Whitman A. Mahalia Jackson, Gospel Singer, And a Civil Rights Symbol, Dies (The New York Times obituary, January 28, 1972)",
      "publisher": "The New York Times (On This Day archive)",
      "url": "https://archive.nytimes.com/www.nytimes.com/learning/general/onthisday/bday/1026.html",
      "source_type": "other",
      "published": "1972-01-28",
      "accessed": "2026-11-04",
      "rights_note": "Newspaper obituary; facts and short quotations used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Nixon R. Statement on the Death of Mahalia Jackson (January 27, 1972)",
      "publisher": "The American Presidency Project, University of California, Santa Barbara",
      "url": "https://www.presidency.ucsb.edu/documents/statement-the-death-mahalia-jackson",
      "source_type": "other",
      "published": "1972-01-27",
      "accessed": "2026-11-04",
      "rights_note": "Public presidential statement with an editorial note; used for the place and circumstances of death."
    },
    {
      "source_id": "SRC-0003",
      "title": "Mahalia Jackson (This Far by Faith)",
      "publisher": "PBS",
      "url": "https://www.pbs.org/thisfarbyfaith/popup/3_mahalia_jackson.html",
      "source_type": "other",
      "accessed": "2026-11-04",
      "rights_note": "Public broadcaster's biography; used for the cause of death it gives and the year of the move to Chicago."
    },
    {
      "source_id": "SRC-0004",
      "title": "Mahalia: 4 Key Facts About Mahalia Jackson's Life the Lifetime Movie Missed",
      "publisher": "TheWrap",
      "url": "https://www.thewrap.com/mahalia-jackson-lifetime-biopic-key-facts-missed/",
      "source_type": "other",
      "published": "2021-04-03",
      "accessed": "2026-11-04",
      "rights_note": "Entertainment news article summarizing her biography; used with citation for the sarcoidosis account."
    },
    {
      "source_id": "SRC-0005",
      "title": "Mahalia Jackson",
      "publisher": "Wikipedia",
      "url": "https://en.wikipedia.org/wiki/Mahalia_Jackson",
      "source_type": "other",
      "accessed": "2026-11-04",
      "rights_note": "Tertiary source citing Laurraine Goreau's biography Just Mahalia, Baby and her autobiography; used for the health history it attributes to them and as a pointer to its sources."
    },
    {
      "source_id": "SRC-0006",
      "title": "Mahalia Jackson",
      "publisher": "Biography.com (A&E Television Networks)",
      "url": "https://www.biography.com/musicians/a52954124/mahalia-jackson",
      "source_type": "other",
      "published": "2021-04-05",
      "accessed": "2026-11-04",
      "rights_note": "Popular biography; used for the last concert in Munich and the cause of death it gives."
    },
    {
      "source_id": "SRC-0007",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-04",
      "accessed": "2026-11-04",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    },
    {
      "source_id": "SRC-0008",
      "title": "Mahalia Jackson Theater for the Performing Arts",
      "publisher": "New Orleans Historical (University of New Orleans)",
      "url": "https://neworleanshistorical.org/items/show/977",
      "source_type": "other",
      "accessed": "2026-11-04",
      "rights_note": "Local history site; used for the collapse in Munich and the cause and place of death it gives."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-02-09",
    "index_age": 52,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Diagnose and treat sarcoidosis with cardiac involvement in a 52-year-old Black woman and touring singer, in whom sarcoidosis is more common and more often severe and fatal than in White Americans, on the ATS 2020 diagnosis guideline, the ERS 2021 treatment guideline, the HRS 2014 cardiac sarcoidosis consensus and the AHA 2024 scientific statement: chest imaging with bilateral hilar adenopathy; pulmonary function with DLCO; EBUS-guided lymph node aspiration showing non-necrotizing granulomas, with tuberculosis and fungal infection excluded; screening every patient for other organ involvement (eye examination, ECG, calcium and vitamin D handling, liver and kidney tests); cardiac evaluation with ECG, Holter monitoring, echocardiography, cardiac MRI and FDG-PET before treatment begins; prednisone with methotrexate as a steroid-sparing agent, with methotrexate safety monitoring; bone protection that avoids calcium supplements while calcium is high; pneumocystis prophylaxis, vaccination and tuberculosis screening before immunosuppression; arrhythmia risk stratification with electrophysiology study and a defibrillator; and a plan that protects her voice, her performing and her travel.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-02-09",
        "purpose": "Three months of breathlessness, cough, tiredness and palpitations in a touring singer of 52: examination, chest radiograph, ECG and blood tests"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-02-23",
        "purpose": "EBUS result: sarcoidosis; pulmonology consultation, lung function, screening for other organ involvement, and cardiac tests"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-03-09",
        "purpose": "Cardiac MRI and FDG-PET results: cardiac sarcoidosis; start of prednisone and methotrexate, bone and infection protection, and electrophysiology referral"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-05-11",
        "purpose": "Nine weeks of treatment: lung function, calcium, methotrexate safety, the new defibrillator, steroid effects, and her concert schedule"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-06-15",
        "purpose": "Same-day sick visit for laryngitis on immunosuppressive treatment"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-08-24",
        "purpose": "Six months of treatment: repeat FDG-PET, steroid taper, and plans for touring"
      },
      {
        "encounter_id": "ENC-007",
        "date": "2026-10-05",
        "purpose": "Periodic adult preventive visit"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Breathlessness on exertion and a dry cough for three months, worse on tour, with tiredness and chest tightness; she can no longer hold long phrases; bilateral hilar lymph node enlargement on today's chest radiograph; granulomas were reported at an abdominal operation twelve years ago, with no pathology report available: sarcoidosis must be confirmed by tissue and other causes excluded",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R06.09",
            "display": "Other forms of dyspnea",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic presenting problem anchored to the documented breathlessness during performances and the 1952 granulomas. Superseded by the tissue diagnosis at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-02-23"
      },
      {
        "id": "PRB-002",
        "display": "Palpitations with two spells of light-headedness while singing; ECG today: sinus rhythm with first-degree atrioventricular block (PR 240 ms) and frequent ventricular ectopic beats: cardiac involvement must be looked for",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R00.2",
            "display": "Palpitations",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic finding; superseded when cardiac sarcoidosis was diagnosed.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-03-09"
      },
      {
        "id": "PRB-003",
        "display": "Hypercalcemia: calcium 10.8 mg/dL with a high 1,25-dihydroxyvitamin D and a low 25-hydroxyvitamin D, while taking an over-the-counter calcium and vitamin D supplement; creatinine slightly raised",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E83.52",
            "display": "Hypercalcemia",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic finding; resolved on treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-05-11"
      },
      {
        "id": "PRB-004",
        "display": "Pulmonary sarcoidosis with hilar and mediastinal lymph node involvement (Scadding stage II), confirmed by non-necrotizing granulomas on EBUS-guided lymph node aspiration with negative stains and cultures; mild restriction and reduced diffusing capacity; synthetic modern detail linked to her documented sarcoidosis",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "D86.2",
            "display": "Sarcoidosis of lung with sarcoidosis of lymph nodes",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic histology, stage and lung function; her biographer reports a diagnosis of sarcoidosis after granulomas were found at an operation (D, probable).",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-02-23"
      },
      {
        "id": "PRB-008",
        "display": "Acute viral laryngitis: three days of hoarseness, a sore throat and a mild dry cough after a cold, without fever, on prednisone 20 mg and methotrexate; rapid influenza and COVID-19 tests negative; no thrush; resolved",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "J04.0",
            "display": "Acute laryngitis",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic acute infection; not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-06-15",
        "abatement_date": "2026-08-24"
      },
      {
        "id": "PRB-005",
        "display": "Cardiac sarcoidosis: first-degree atrioventricular block, ventricular ectopy (6 percent of beats) with nonsustained ventricular tachycardia, left ventricular ejection fraction 47 percent, patchy late gadolinium enhancement of the basal septum and inferolateral wall, and matching focal FDG uptake on PET; synthetic modern detail linked to the documented private account that sarcoidosis was in her heart",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "D86.85",
            "display": "Sarcoid myocarditis",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic cardiac findings; the account that her doctors told her sarcoidosis was in her heart rests on her biographer (D, probable), and the interpretation of her later heart disease is R.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-03-09"
      },
      {
        "id": "PRB-007",
        "display": "Long-term systemic glucocorticoid treatment for sarcoidosis, with bone, glucose, blood pressure, infection and eye risks to manage",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "Z79.52",
            "display": "Long term (current) use of systemic steroids",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic treatment status.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-03-09"
      },
      {
        "id": "PRB-006",
        "display": "Dual-chamber implantable cardioverter-defibrillator, placed after sustained monomorphic ventricular tachycardia was induced at electrophysiology study; remote monitoring",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "Z95.810",
            "display": "Presence of automatic (implantable) cardiac defibrillator",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic device status after the synthetic implant.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-05-11"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Prednisone 20 mg oral tablet, two tablets (40 mg) by mouth each morning",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312615",
            "display": "prednisone 20 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 2,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "40 mg each morning"
        },
        "start_date": "2026-03-09",
        "end_date": "2026-05-11",
        "indication_problem_ids": [
          "PRB-004",
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic initial glucocorticoid dose for cardiac and pulmonary sarcoidosis (about 0.45 mg/kg).",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Prednisone 10 mg oral tablet, three tablets (30 mg) by mouth each morning for four weeks",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198145",
            "display": "prednisone 10 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 3,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "30 mg each morning for four weeks"
        },
        "start_date": "2026-05-11",
        "end_date": "2026-06-08",
        "indication_problem_ids": [
          "PRB-004",
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic first step of the taper, decided at the nine-week review.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Prednisone 20 mg oral tablet, one tablet (20 mg) by mouth each morning for four weeks",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312615",
            "display": "prednisone 20 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "20 mg each morning for four weeks"
        },
        "start_date": "2026-06-08",
        "end_date": "2026-07-06",
        "indication_problem_ids": [
          "PRB-004",
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic second step of the taper planned at the nine-week review.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Prednisone 5 mg oral tablet, three tablets (15 mg) by mouth each morning for four weeks",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312617",
            "display": "prednisone 5 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 3,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "15 mg each morning for four weeks"
        },
        "start_date": "2026-07-06",
        "end_date": "2026-08-03",
        "indication_problem_ids": [
          "PRB-004",
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic third step of the taper planned at the nine-week review.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Prednisone 10 mg oral tablet, one tablet (10 mg) by mouth each morning",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198145",
            "display": "prednisone 10 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "10 mg each morning"
        },
        "start_date": "2026-08-03",
        "end_date": "2026-09-21",
        "indication_problem_ids": [
          "PRB-004",
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic fourth step of the taper planned at the nine-week review.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Prednisone 5 mg oral tablet, one and a half tablets (7.5 mg) by mouth each morning",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312617",
            "display": "prednisone 5 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1.5,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "7.5 mg each morning"
        },
        "start_date": "2026-09-21",
        "indication_problem_ids": [
          "PRB-004",
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic next step of the taper, decided at the six-month review after the repeat FDG-PET.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "MED-007",
        "display": "Methotrexate 2.5 mg oral tablet, six tablets (15 mg) by mouth once a week on Sundays",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "105585",
            "display": "methotrexate 2.5 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 6,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "wk",
          "text": "15 mg once weekly"
        },
        "start_date": "2026-03-09",
        "end_date": "2026-05-11",
        "indication_problem_ids": [
          "PRB-004",
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic steroid-sparing agent started with prednisone for cardiac sarcoidosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "MED-008",
        "display": "Methotrexate 2.5 mg oral tablet, eight tablets (20 mg) by mouth once a week on Sundays",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "105585",
            "display": "methotrexate 2.5 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 8,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "wk",
          "text": "20 mg once weekly"
        },
        "start_date": "2026-05-11",
        "indication_problem_ids": [
          "PRB-004",
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic dose increase to the target dose as prednisone is tapered.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "MED-009",
        "display": "Folic acid 1 mg oral tablet, one tablet by mouth daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "310410",
            "display": "folic acid 1 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-03-09",
        "indication_problem_ids": [
          "PRB-004",
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic folic acid to reduce methotrexate side effects.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "MED-010",
        "display": "Atovaquone 750 mg/5 mL oral suspension, 1500 mg (10 mL) by mouth once daily with food",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "308429",
            "display": "atovaquone 150 MG/ML Oral Suspension",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1500,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "1500 mg once daily with food"
        },
        "start_date": "2026-03-09",
        "end_date": "2026-07-06",
        "indication_problem_ids": [
          "PRB-004",
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic pneumocystis prophylaxis while prednisone was 20 mg or more with methotrexate; atovaquone rather than trimethoprim-sulfamethoxazole, which adds to methotrexate's marrow toxicity.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "MED-011",
        "display": "Alendronate 70 mg oral tablet, one tablet by mouth once weekly on rising, with a full glass of water, staying upright for 30 minutes",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "904431",
            "display": "alendronate sodium 70 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "wk",
          "text": "One tablet once weekly"
        },
        "start_date": "2026-03-16",
        "indication_problem_ids": [
          "PRB-007"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic bone protection on long-term glucocorticoids after a bone density scan (moderate fracture risk).",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "MED-012",
        "display": "Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "866427",
            "display": "24 HR metoprolol succinate 25 MG Extended Release Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-03-09",
        "indication_problem_ids": [
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic beta-blocker for ventricular ectopy and nonsustained ventricular tachycardia with a mildly reduced ejection fraction.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "MED-013",
        "display": "Cholecalciferol (vitamin D3) 25 mcg (1000 units) oral tablet, one tablet by mouth daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "199362",
            "display": "cholecalciferol 0.025 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-05-11",
        "indication_problem_ids": [
          "PRB-007"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic cautious vitamin D replacement once calcium was normal, with calcium rechecked.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 12.4,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic blood count at presentation; low lymphocyte count, common in active sarcoidosis. No result from her life is known; synthetic value.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V1",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 4.6,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic blood count at presentation; low lymphocyte count, common in active sarcoidosis. No result from her life is known; synthetic value.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-LYM-V1",
        "display": "Lymphocytes [#/volume] in Blood by Automated count",
        "label": "Lymphocyte count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 0.9,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.0,
          "high": 4.8
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "731-0",
            "display": "Lymphocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic blood count at presentation; low lymphocyte count, common in active sarcoidosis. No result from her life is known; synthetic value.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 232,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic blood count at presentation; low lymphocyte count, common in active sarcoidosis. No result from her life is known; synthetic value.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 140,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation: raised calcium and alkaline phosphatase, creatinine slightly above range.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 4.1,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation: raised calcium and alkaline phosphatase, creatinine slightly above range.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 1.08,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation: raised calcium and alkaline phosphatase, creatinine slightly above range.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 62,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation: raised calcium and alkaline phosphatase, creatinine slightly above range.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 104,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation: raised calcium and alkaline phosphatase, creatinine slightly above range.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-CA-V1",
        "display": "Calcium [Mass/volume] in Serum or Plasma",
        "label": "Calcium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 10.8,
        "unit": "mg/dL",
        "reference_range": {
          "low": 8.6,
          "high": 10.3
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "17861-6",
            "display": "Calcium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation: raised calcium and alkaline phosphatase, creatinine slightly above range.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 28,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation: raised calcium and alkaline phosphatase, creatinine slightly above range.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V1",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 30,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation: raised calcium and alkaline phosphatase, creatinine slightly above range.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALP-V1",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 128,
        "unit": "U/L",
        "reference_range": {
          "low": 35,
          "high": 104
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation: raised calcium and alkaline phosphatase, creatinine slightly above range.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V1",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 4.0,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation: raised calcium and alkaline phosphatase, creatinine slightly above range.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V1",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 5.9,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; 5.7 to 6.4% prediabetes; 6.5% or more diabetes"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic A1c; prediabetes, relevant before glucocorticoids.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-VD25-V1",
        "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
        "label": "25-hydroxyvitamin D",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 22,
        "unit": "ng/mL",
        "reference_range": {
          "low": 30,
          "high": 100
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "62292-8",
            "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic 25-hydroxyvitamin D; low.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-VD125-V1",
        "display": "1,25-Dihydroxyvitamin D [Mass/volume] in Serum or Plasma",
        "label": "1,25-dihydroxyvitamin D",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 84,
        "unit": "pg/mL",
        "reference_range": {
          "low": 18,
          "high": 72
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "62290-2",
            "display": "1,25-Dihydroxyvitamin D [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic 1,25-dihydroxyvitamin D; high, from activation of vitamin D by granulomas.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-BNP-V1",
        "display": "Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma",
        "label": "NT-proBNP",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 210,
        "unit": "pg/mL",
        "reference_range": {
          "high": 125
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "33762-6",
            "display": "Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic NT-proBNP; mildly raised.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V1",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 1.8,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.4,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic TSH; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V1",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-02-09",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen; negative. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-FVCP-V2",
        "display": "FVC measured/predicted",
        "label": "FVC percent predicted",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-02-23",
        "value": 74,
        "unit": "%",
        "reference_range": {
          "low": 80
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19872-1",
            "display": "FVC measured/predicted",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic pulmonary function at the consultation: mild restriction pattern with a reduced diffusing capacity.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-FEV1P-V2",
        "display": "FEV1 measured/predicted",
        "label": "FEV1 percent predicted",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-02-23",
        "value": 76,
        "unit": "%",
        "reference_range": {
          "low": 80
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "20152-5",
            "display": "FEV1 measured/predicted",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic pulmonary function at the consultation: mild restriction pattern with a reduced diffusing capacity.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-RATIO-V2",
        "display": "FEV1/FVC",
        "label": "FEV1/FVC ratio",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-02-23",
        "value": 80,
        "unit": "%",
        "reference_range": {
          "low": 70
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19926-5",
            "display": "FEV1/FVC",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic pulmonary function at the consultation: mild restriction pattern with a reduced diffusing capacity.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-DLCOP-V2",
        "display": "Diffusion capacity.carbon monoxide/Predicted",
        "label": "DLCO percent predicted",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-02-23",
        "value": 62,
        "unit": "%",
        "reference_range": {
          "low": 80
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98130-8",
            "display": "Diffusion capacity.carbon monoxide/Predicted",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic pulmonary function at the consultation: mild restriction pattern with a reduced diffusing capacity.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-CA-V2",
        "display": "Calcium [Mass/volume] in Serum or Plasma",
        "label": "Calcium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 10.7,
        "unit": "mg/dL",
        "reference_range": {
          "low": 8.6,
          "high": 10.3
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "17861-6",
            "display": "Calcium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic calcium two weeks after stopping her calcium supplement.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V2",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 1.04,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic creatinine.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V2",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 65,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic eGFR.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V2",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-02-23",
        "value": 6,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 at the diagnosis visit; item 9 scored 0. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V3",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 12.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic baseline blood count before methotrexate.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V3",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 4.8,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic baseline blood count before methotrexate.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-LYM-V3",
        "display": "Lymphocytes [#/volume] in Blood by Automated count",
        "label": "Lymphocyte count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 0.9,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.0,
          "high": 4.8
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "731-0",
            "display": "Lymphocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic baseline blood count before methotrexate.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V3",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 240,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic baseline blood count before methotrexate.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V3",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 1.02,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic baseline chemistry before methotrexate and prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V3",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 66,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic baseline chemistry before methotrexate and prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V3",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 101,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic baseline chemistry before methotrexate and prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-CA-V3",
        "display": "Calcium [Mass/volume] in Serum or Plasma",
        "label": "Calcium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 10.6,
        "unit": "mg/dL",
        "reference_range": {
          "low": 8.6,
          "high": 10.3
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "17861-6",
            "display": "Calcium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic baseline chemistry before methotrexate and prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V3",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 27,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic baseline chemistry before methotrexate and prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V3",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 29,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic baseline chemistry before methotrexate and prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALP-V3",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 124,
        "unit": "U/L",
        "reference_range": {
          "low": 35,
          "high": 104
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic baseline chemistry before methotrexate and prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V3",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 4.0,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic baseline chemistry before methotrexate and prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-BNP-V3",
        "display": "Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma",
        "label": "NT-proBNP",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 240,
        "unit": "pg/mL",
        "reference_range": {
          "high": 125
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "33762-6",
            "display": "Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic NT-proBNP at the cardiac diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V3",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-03-09",
        "value": 7,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V4",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-11",
        "value": 13.1,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count on prednisone and methotrexate; white count raised by prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V4",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-11",
        "value": 9.8,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count on prednisone and methotrexate; white count raised by prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-LYM-V4",
        "display": "Lymphocytes [#/volume] in Blood by Automated count",
        "label": "Lymphocyte count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-11",
        "value": 1.2,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.0,
          "high": 4.8
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "731-0",
            "display": "Lymphocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count on prednisone and methotrexate; white count raised by prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V4",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-11",
        "value": 262,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count on prednisone and methotrexate; white count raised by prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V4",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-11",
        "value": 139,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry on treatment: calcium and alkaline phosphatase normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-K-V4",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-11",
        "value": 3.9,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry on treatment: calcium and alkaline phosphatase normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V4",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-11",
        "value": 0.92,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry on treatment: calcium and alkaline phosphatase normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V4",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-11",
        "value": 75,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry on treatment: calcium and alkaline phosphatase normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V4",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-11",
        "value": 118,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry on treatment: calcium and alkaline phosphatase normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-CA-V4",
        "display": "Calcium [Mass/volume] in Serum or Plasma",
        "label": "Calcium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-11",
        "value": 9.6,
        "unit": "mg/dL",
        "reference_range": {
          "low": 8.6,
          "high": 10.3
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "17861-6",
            "display": "Calcium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry on treatment: calcium and alkaline phosphatase normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V4",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-11",
        "value": 31,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry on treatment: calcium and alkaline phosphatase normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V4",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-11",
        "value": 28,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry on treatment: calcium and alkaline phosphatase normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALP-V4",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-11",
        "value": 96,
        "unit": "U/L",
        "reference_range": {
          "low": 35,
          "high": 104
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry on treatment: calcium and alkaline phosphatase normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V4",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-11",
        "value": 4.1,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry on treatment: calcium and alkaline phosphatase normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V4",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-11",
        "value": 6.3,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; 5.7 to 6.4% prediabetes; 6.5% or more diabetes"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic A1c after three months, nine weeks of them on prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-VD25-V4",
        "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
        "label": "25-hydroxyvitamin D",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-11",
        "value": 24,
        "unit": "ng/mL",
        "reference_range": {
          "low": 30,
          "high": 100
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "62292-8",
            "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic 25-hydroxyvitamin D; still low.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-BNP-V4",
        "display": "Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma",
        "label": "NT-proBNP",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-11",
        "value": 140,
        "unit": "pg/mL",
        "reference_range": {
          "high": 125
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "33762-6",
            "display": "Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic NT-proBNP on treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-FVCP-V4",
        "display": "FVC measured/predicted",
        "label": "FVC percent predicted",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-05-11",
        "value": 84,
        "unit": "%",
        "reference_range": {
          "low": 80
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19872-1",
            "display": "FVC measured/predicted",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic pulmonary function after nine weeks of treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-FEV1P-V4",
        "display": "FEV1 measured/predicted",
        "label": "FEV1 percent predicted",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-05-11",
        "value": 85,
        "unit": "%",
        "reference_range": {
          "low": 80
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "20152-5",
            "display": "FEV1 measured/predicted",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic pulmonary function after nine weeks of treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-RATIO-V4",
        "display": "FEV1/FVC",
        "label": "FEV1/FVC ratio",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-05-11",
        "value": 80,
        "unit": "%",
        "reference_range": {
          "low": 70
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19926-5",
            "display": "FEV1/FVC",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic pulmonary function after nine weeks of treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-DLCOP-V4",
        "display": "Diffusion capacity.carbon monoxide/Predicted",
        "label": "DLCO percent predicted",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-05-11",
        "value": 70,
        "unit": "%",
        "reference_range": {
          "low": 80
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98130-8",
            "display": "Diffusion capacity.carbon monoxide/Predicted",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic pulmonary function after nine weeks of treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V4",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-05-11",
        "value": 5,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V5",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 13.0,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count on methotrexate.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V5",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 8.1,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count on methotrexate.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-LYM-V5",
        "display": "Lymphocytes [#/volume] in Blood by Automated count",
        "label": "Lymphocyte count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 1.4,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.0,
          "high": 4.8
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "731-0",
            "display": "Lymphocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count on methotrexate.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V5",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 248,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count on methotrexate.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V5",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 0.9,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry on methotrexate.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V5",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 77,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry on methotrexate.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V5",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 108,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry on methotrexate.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-CA-V5",
        "display": "Calcium [Mass/volume] in Serum or Plasma",
        "label": "Calcium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 9.5,
        "unit": "mg/dL",
        "reference_range": {
          "low": 8.6,
          "high": 10.3
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "17861-6",
            "display": "Calcium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry on methotrexate.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V5",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 29,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry on methotrexate.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V5",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 27,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry on methotrexate.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALP-V5",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 90,
        "unit": "U/L",
        "reference_range": {
          "low": 35,
          "high": 104
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry on methotrexate.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V5",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 4.1,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry on methotrexate.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V5",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 6.2,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; 5.7 to 6.4% prediabetes; 6.5% or more diabetes"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic A1c as prednisone is tapered.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-VD25-V5",
        "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
        "label": "25-hydroxyvitamin D",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 34,
        "unit": "ng/mL",
        "reference_range": {
          "low": 30,
          "high": 100
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "62292-8",
            "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic 25-hydroxyvitamin D on cholecalciferol.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-BNP-V5",
        "display": "Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma",
        "label": "NT-proBNP",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 96,
        "unit": "pg/mL",
        "reference_range": {
          "high": 125
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "33762-6",
            "display": "Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic NT-proBNP; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-FVCP-V5",
        "display": "FVC measured/predicted",
        "label": "FVC percent predicted",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-08-24",
        "value": 90,
        "unit": "%",
        "reference_range": {
          "low": 80
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19872-1",
            "display": "FVC measured/predicted",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic pulmonary function after six months of treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-FEV1P-V5",
        "display": "FEV1 measured/predicted",
        "label": "FEV1 percent predicted",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-08-24",
        "value": 89,
        "unit": "%",
        "reference_range": {
          "low": 80
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "20152-5",
            "display": "FEV1 measured/predicted",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic pulmonary function after six months of treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-RATIO-V5",
        "display": "FEV1/FVC",
        "label": "FEV1/FVC ratio",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-08-24",
        "value": 79,
        "unit": "%",
        "reference_range": {
          "low": 70
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19926-5",
            "display": "FEV1/FVC",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic pulmonary function after six months of treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-DLCOP-V5",
        "display": "Diffusion capacity.carbon monoxide/Predicted",
        "label": "DLCO percent predicted",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-08-24",
        "value": 76,
        "unit": "%",
        "reference_range": {
          "low": 80
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98130-8",
            "display": "Diffusion capacity.carbon monoxide/Predicted",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic pulmonary function after six months of treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V5",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-08-24",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V7",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 204,
        "unit": "mg/dL",
        "reference_range": {
          "high": 200
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid screen at 52.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V7",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 54,
        "unit": "mg/dL",
        "reference_range": {
          "low": 50
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid screen at 52.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V7",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 126,
        "unit": "mg/dL",
        "reference_range": {
          "high": 129
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid screen at 52.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V7",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 118,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid screen at 52.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V7",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-10-05",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 at the preventive visit; item 9 scored 0. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Chest radiograph, two views: bilateral symmetric hilar lymph node enlargement with right paratracheal widening and fine reticulonodular opacities in both upper zones; heart size normal; no effusion",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "399208008",
            "display": "Plain X-ray of chest",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-02-09",
          "end": "2026-02-09"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic imaging at the first visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "Resting 12-lead ECG: sinus rhythm 84 per minute, PR interval 240 ms (first-degree atrioventricular block), QRS 100 ms, frequent unifocal ventricular ectopic beats; no Q waves; no previous ECG for comparison",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "29303009",
            "display": "Electrocardiographic procedure",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-02-09",
          "end": "2026-02-09"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic ECG at the first visit, done for palpitations and as the baseline screen every patient with suspected sarcoidosis needs.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "High-resolution CT of the chest: symmetric hilar, subcarinal and right paratracheal lymph nodes up to 2.4 cm, some with fine calcification; perilymphatic micronodules along the bronchovascular bundles and fissures in both upper lobes; no fibrosis, traction bronchiectasis or mass",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "169069000",
            "display": "CT of chest",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-02-11",
          "end": "2026-02-11"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic imaging two days after the first visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "PROC-004",
        "display": "Endobronchial ultrasound-guided transbronchial needle aspiration of lymph node stations 4R, 7 and 11L under moderate sedation, with bronchoalveolar lavage: non-necrotizing granulomas at all three stations; acid-fast and fungal stains negative; mycobacterial and fungal cultures sent; lavage lymphocytes 32 percent with a CD4 to CD8 ratio of 5.2; no malignant cells",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "1137699004",
            "display": "Endoscopic endobronchial ultrasonography guided transbronchial needle aspiration of mediastinal lymph node",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-02-18",
          "end": "2026-02-18"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic tissue diagnosis arranged by pulmonology from the referral.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "PROC-017",
        "display": "Advance care planning conversation, about 30 minutes, including her wishes about the defibrillator",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-10-05",
          "end": "2026-10-05"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning; records only her own general preferences.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "PROC-005",
        "display": "Full pulmonary function tests (spirometry, lung volumes and diffusing capacity): FVC 74 percent, FEV1 76 percent of predicted, FEV1/FVC 80 percent, total lung capacity 78 percent, DLCO 62 percent of predicted: mild restriction with a reduced diffusing capacity",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "23426006",
            "display": "Measurement of respiratory function",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-02-23",
          "end": "2026-02-23"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic lung function at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "PROC-006",
        "display": "24-hour Holter monitoring: sinus rhythm 58 to 112 per minute; PR interval 230 to 250 ms throughout; ventricular ectopic beats 6 percent of all beats, unifocal; three runs of nonsustained ventricular tachycardia of up to 8 beats; no second- or third-degree atrioventricular block; palpitations recorded during a run of ectopic beats",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "427047002",
            "display": "Holter extended electrocardiographic recording",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-02-24",
          "end": "2026-02-24"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic ambulatory monitoring.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "PROC-007",
        "display": "Transthoracic echocardiogram: left ventricular ejection fraction 47 percent with thinning and hypokinesis of the basal anteroseptum; normal right ventricle; normal valves; estimated pulmonary artery systolic pressure 28 mmHg; no pericardial effusion",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "40701008",
            "display": "Echocardiography",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-02-26",
          "end": "2026-02-26"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic echocardiogram.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "PROC-008",
        "display": "Cardiac MRI with late gadolinium enhancement: left ventricular ejection fraction 47 percent; patchy mid-wall and subepicardial enhancement of the basal anteroseptum and inferolateral wall (about 9 percent of left ventricular mass), with raised T2 signal in the basal septum; right ventricle normal",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "241620005",
            "display": "Cardiac MRI",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-03-03",
          "end": "2026-03-03"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic cardiac MRI.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "PROC-009",
        "display": "Dilated eye examination by ophthalmology: no anterior or posterior uveitis, no conjunctival nodules, intraocular pressure 15 and 16 mmHg, no cataract",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "36228007",
            "display": "Ophthalmic examination and evaluation",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-03-04",
          "end": "2026-03-04"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic baseline eye screening for every patient with sarcoidosis, before glucocorticoids.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "PROC-010",
        "display": "Cardiac FDG-PET with perfusion imaging, after 72 hours of a high-fat, very-low-carbohydrate diet and an overnight fast: focal FDG uptake in the basal anteroseptum and lateral wall (maximum SUV 6.2) matching the MRI enhancement, with a mild perfusion defect at the same sites; FDG-avid hilar and mediastinal lymph nodes; no uptake elsewhere outside the chest",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "241439007",
            "display": "PET heart study",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-03-06",
          "end": "2026-03-06"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic PET before any glucocorticoid, so that the result is not blunted by treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "PROC-013",
        "display": "Bone density scan (DXA): lumbar spine T-score -1.2, femoral neck T-score -1.6; FRAX adjusted for prednisone of 7.5 mg or more: major osteoporotic fracture 9 percent and hip fracture 1.2 percent at ten years (moderate risk)",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "312681000",
            "display": "Bone density scan",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-03-16",
          "end": "2026-03-16"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic bone density at the start of long-term glucocorticoids.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "PROC-011",
        "display": "Electrophysiology study: HV interval 58 ms; sustained monomorphic ventricular tachycardia (220 per minute) induced with double extrastimuli from the right ventricular apex, ended by overdrive pacing",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "82982002",
            "display": "Cardiac electrophysiologic stimulation and recording study",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-03-18",
          "end": "2026-03-18"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic risk stratification for a left ventricular ejection fraction above 35 percent with scar and nonsustained ventricular tachycardia.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "PROC-012",
        "display": "Implantation of a dual-chamber transvenous cardioverter-defibrillator through the left subclavian vein, programmed with ventricular tachycardia therapies and minimal ventricular pacing; enrolled in remote monitoring; no complications",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "395218007",
            "display": "Implantation of internal cardiac defibrillator",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-03-19",
          "end": "2026-03-19"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic defibrillator after inducible sustained ventricular tachycardia; dual chamber because of the conduction disease.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "PROC-014",
        "display": "Repeat spirometry and diffusing capacity after nine weeks of treatment: FVC 84 percent and FEV1 85 percent of predicted, FEV1/FVC 80 percent, DLCO 70 percent of predicted",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "23426006",
            "display": "Measurement of respiratory function",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-05-11",
          "end": "2026-05-11"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic lung function on treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "PROC-015",
        "display": "Repeat cardiac FDG-PET with the same preparation after five months of treatment: no myocardial FDG uptake; perfusion normal; hilar and mediastinal nodes smaller with low uptake",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "241439007",
            "display": "PET heart study",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-08-17",
          "end": "2026-08-17"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic response assessment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "PROC-016",
        "display": "Repeat transthoracic echocardiogram: left ventricular ejection fraction 54 percent; basal septal thinning unchanged; normal right ventricle",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "40701008",
            "display": "Echocardiography",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-08-17",
          "end": "2026-08-17"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic echocardiogram with the repeat PET.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "PROC-018",
        "display": "Repeat spirometry and diffusing capacity after six months of treatment: FVC 90 percent and FEV1 89 percent of predicted, FEV1/FVC 79 percent, DLCO 76 percent of predicted",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "23426006",
            "display": "Measurement of respiratory function",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-08-24",
          "end": "2026-08-24"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic lung function on treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Tdap vaccine",
        "status": "completed",
        "date": "2020-11-16",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult immunization history in the modern frame; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Influenza vaccine, this season (inactivated), late in the season",
        "status": "completed",
        "date": "2026-02-09",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic influenza vaccination at the first visit, before any immunosuppression.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Pneumococcal conjugate vaccine (PCV20), before immunosuppression",
        "status": "completed",
        "date": "2026-03-09",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pneumococcal vaccination before glucocorticoids and methotrexate.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-004",
        "display": "Recombinant zoster vaccine, dose 1 of 2",
        "status": "completed",
        "date": "2026-03-09",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first zoster dose for an adult over 50 starting immunosuppression.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-005",
        "display": "Hepatitis B vaccine (adjuvanted, two-dose series), dose 1",
        "status": "completed",
        "date": "2026-03-09",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hepatitis B vaccination for a non-immune adult.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-006",
        "display": "Hepatitis B vaccine (adjuvanted, two-dose series), dose 2",
        "status": "completed",
        "date": "2026-05-11",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second hepatitis B dose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-007",
        "display": "Recombinant zoster vaccine, dose 2 of 2",
        "status": "completed",
        "date": "2026-08-24",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second zoster dose, five and a half months after the first.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-008",
        "display": "Influenza vaccine, this season (inactivated)",
        "status": "completed",
        "date": "2026-10-05",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic yearly influenza vaccination.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-009",
        "display": "COVID-19 mRNA vaccine, this season's formula",
        "status": "completed",
        "date": "2026-10-05",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "309",
            "display": "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal COVID-19 vaccination.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      }
    ],
    "family_history": [
      {
        "id": "FH-001",
        "relationship": {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode",
          "code": "MTH",
          "display": "mother"
        },
        "condition": "Died when she was six; cause not recorded in the cited source",
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0001"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      }
    ],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Breathlessness and abdominal cramping during a concert tour abroad at 40, with weight loss and a cancelled tour; hysterectomy afterwards, at which granulomas were reported in the abdomen and sarcoidosis was diagnosed; no pathology report available",
        "historical_date": {
          "iso": "1952",
          "display": "1952",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "Three months of breathlessness, cough, tiredness and palpitations in a touring singer of 52: examination, chest radiograph, ECG and blood tests",
        "status": "finished",
        "date": "2026-02-09",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "EBUS result: sarcoidosis; pulmonology consultation, lung function, screening for other organ involvement, and cardiac tests",
        "status": "finished",
        "date": "2026-02-23",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "EBUS result and pulmonology consultation",
          "hpi": {
            "narrative": "Ms. Jackson returns two weeks after her first visit. The CT of the chest two days after that visit showed enlarged hilar and mediastinal lymph nodes and small nodules along the airways in both upper lobes. EBUS-guided needle aspiration five days ago found non-necrotizing granulomas in three lymph node stations, with negative stains for mycobacteria and fungi; cultures are growing nothing so far. The interferon-gamma release assay and HIV test from the first visit were negative. She stopped the over-the-counter calcium and vitamin D tablets as advised. Her breathlessness and cough are unchanged, and she had one more spell of palpitations while singing at church. She has postponed her concerts for the next three weeks. Dr. Asante-Miller saw her this morning, and she had full lung function tests. She has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "Tissue",
                "value": "Non-necrotizing granulomas at stations 4R, 7 and 11L; stains negative; cultures pending; lavage lymphocytes 32 percent, CD4 to CD8 ratio 5.2"
              },
              {
                "label": "Infection excluded so far",
                "value": "Interferon-gamma release assay and HIV negative; acid-fast and fungal stains negative"
              },
              {
                "label": "Lung function",
                "value": "FVC 74 percent and DLCO 62 percent of predicted"
              },
              {
                "label": "Symptoms",
                "value": "Breathlessness and cough unchanged; one more spell of palpitations"
              },
              {
                "label": "Work",
                "value": "Concerts postponed for three weeks"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired; no fever, night sweats or weight loss"
            },
            {
              "system": "Respiratory",
              "status": "positive",
              "finding": "Breathless on one flight of stairs; dry cough"
            },
            {
              "system": "Cardiovascular",
              "status": "positive",
              "finding": "One spell of palpitations with light-headedness; no chest pain or fainting"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No redness, pain or blurred vision"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash, nodules or plaques"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Anxious about singing again; PHQ-9 6; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 91.6 kg; blood pressure 126/78, pulse 82 and irregular with ectopic beats; oxygen saturation 95 percent"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation; no crackles"
            },
            {
              "system": "Cardiovascular",
              "finding": "Occasional ectopic beats; no murmur; no ankle swelling"
            },
            {
              "system": "Skin",
              "finding": "No erythema nodosum, plaques or scar infiltration"
            },
            {
              "system": "Lymph nodes",
              "finding": "No palpable cervical, axillary or inguinal nodes"
            },
            {
              "system": "Psychiatric",
              "finding": "Warm, direct, worried"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-004",
              "display": "Pulmonary sarcoidosis with lymph node involvement",
              "assessment": "The three ATS criteria are met: a compatible picture (bilateral hilar adenopathy with perilymphatic nodules, lymphopenia, high calcium with a high 1,25-dihydroxyvitamin D), non-necrotizing granulomas on EBUS-guided aspiration, and no sign of tuberculosis, fungal infection or lymphoma so far, with the final cultures to come. Lung function shows mild restriction with a reduced DLCO, and she is symptomatic, so the lungs alone would justify treatment. Sarcoidosis is more common, and more often severe, in Black women. Because the ECG and her palpitations suggest heart involvement, Dr. Asante-Miller advises completing the cardiac tests, including FDG-PET, before any prednisone, which would blunt the PET",
              "plan": [
                "Holter tomorrow; echocardiogram this week; cardiac MRI and FDG-PET with dietary preparation within two weeks",
                "Eye examination by ophthalmology",
                "Hepatitis B and C serology drawn today, before immunosuppression",
                "Treatment decision at the review in two weeks"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Palpitations with first-degree atrioventricular block and ventricular ectopy",
              "assessment": "Suspected cardiac sarcoidosis, to be confirmed or excluded by the tests above; no fainting and no high-grade block",
              "plan": [
                "Call 911 for fainting, chest pain or a sustained racing heart",
                "No driving long distances alone until the Holter result is known"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Hypercalcemia",
              "assessment": "Calcium 10.7 mg/dL two weeks after stopping the supplement, with creatinine 1.04 mg/dL: from granulomas making active vitamin D. Treatment of the sarcoidosis will correct it",
              "plan": [
                "No calcium or vitamin D tablets; ordinary dietary calcium; plenty of fluids; avoid sun overexposure"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Breathlessness and cough with hilar adenopathy",
              "assessment": "Explained by the diagnosis confirmed today; superseded",
              "plan": [
                "Problem resolved"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Tissue diagnosis",
              "cadence": "Once, when the diagnosis is uncertain from the clinical picture",
              "status": "up_to_date",
              "detail": "EBUS-guided needle aspiration rather than mediastinoscopy: non-necrotizing granulomas at three stations; no malignant cells",
              "guideline_ids": [
                "GL-ATS-SARC-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Exclusion of other granulomatous causes",
              "cadence": "At diagnosis",
              "status": "ordered",
              "detail": "Acid-fast and fungal stains negative; mycobacterial and fungal cultures pending, final in six to eight weeks; interferon-gamma release assay and HIV negative from the first visit",
              "guideline_ids": [
                "GL-ATS-SARC-2020"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Spirometry and diffusing capacity (FVC, FEV1, FEV1/FVC, DLCO)",
              "cadence": "At diagnosis, three months after starting treatment, then every three to six months while treatment changes",
              "status": "completed_today",
              "detail": "FVC 74 percent, FEV1 76 percent, FEV1/FVC 80 percent, DLCO 62 percent of predicted: mild restriction with reduced gas transfer",
              "observation_ids": [
                "OBS-FVCP-V2",
                "OBS-FEV1P-V2",
                "OBS-RATIO-V2",
                "OBS-DLCOP-V2"
              ],
              "guideline_ids": [
                "GL-ATS-SARC-2020",
                "GL-ERS-SARC-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Serum calcium",
              "cadence": "At diagnosis, then at each treatment visit while it was raised or vitamin D is given",
              "status": "completed_today",
              "detail": "10.7 mg/dL off the supplement",
              "observation_ids": [
                "OBS-CA-V2"
              ],
              "guideline_ids": [
                "GL-ATS-SARC-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Kidney function",
              "cadence": "At diagnosis, then with calcium checks",
              "status": "completed_today",
              "detail": "Creatinine 1.04 mg/dL, eGFR 65",
              "observation_ids": [
                "OBS-CR-V2",
                "OBS-EGFR-V2"
              ],
              "guideline_ids": [
                "GL-ATS-SARC-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "25-hydroxyvitamin D and 1,25-dihydroxyvitamin D",
              "cadence": "At diagnosis, and before any vitamin D replacement",
              "status": "up_to_date",
              "detail": "From the first visit: 25-hydroxyvitamin D 22 ng/mL (low) and 1,25-dihydroxyvitamin D 84 pg/mL (high), so vitamin D is not to be given while calcium is high",
              "guideline_ids": [
                "GL-ATS-SARC-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests, alkaline phosphatase and blood count",
              "cadence": "At diagnosis",
              "status": "up_to_date",
              "detail": "From the first visit: alkaline phosphatase 128 U/L, ALT 28 U/L; lymphocytes 0.9; to be followed on treatment",
              "guideline_ids": [
                "GL-ATS-SARC-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Baseline ECG",
              "cadence": "At diagnosis for every patient",
              "status": "up_to_date",
              "detail": "First visit: first-degree atrioventricular block and frequent ventricular ectopy",
              "guideline_ids": [
                "GL-ATS-SARC-2020",
                "GL-HRS-CS-2014",
                "GL-AHA-CS-2024"
              ]
            },
            {
              "domain": "examination",
              "measure": "Holter monitoring",
              "cadence": "When the ECG is abnormal or there are palpitations",
              "status": "ordered",
              "detail": "Tomorrow",
              "guideline_ids": [
                "GL-HRS-CS-2014",
                "GL-AHA-CS-2024"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Echocardiogram",
              "cadence": "When cardiac involvement is suspected",
              "status": "ordered",
              "detail": "This week",
              "guideline_ids": [
                "GL-HRS-CS-2014",
                "GL-AHA-CS-2024"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Cardiac MRI with late gadolinium enhancement",
              "cadence": "When cardiac involvement is suspected",
              "status": "ordered",
              "detail": "Within two weeks",
              "guideline_ids": [
                "GL-ATS-SARC-2020",
                "GL-HRS-CS-2014",
                "GL-AHA-CS-2024"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Cardiac FDG-PET",
              "cadence": "When cardiac involvement is suspected, before glucocorticoids",
              "status": "ordered",
              "detail": "Within two weeks, after a 72-hour high-fat, very-low-carbohydrate diet",
              "guideline_ids": [
                "GL-HRS-CS-2014",
                "GL-AHA-CS-2024"
              ]
            },
            {
              "domain": "examination",
              "measure": "Eye examination",
              "cadence": "At diagnosis for every patient, then yearly",
              "status": "ordered",
              "detail": "Ophthalmology appointment next week",
              "guideline_ids": [
                "GL-ATS-SARC-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis B and C screening",
              "cadence": "Before immunosuppressive treatment",
              "status": "ordered",
              "detail": "Hepatitis B surface antigen, core antibody and surface antibody, and hepatitis C antibody drawn today",
              "guideline_ids": [
                "GL-ACR-DMARD-2012",
                "GL-ERS-SARC-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Serum angiotensin-converting enzyme",
              "cadence": "Not used for diagnosis",
              "status": "not_indicated",
              "detail": "Not drawn: its sensitivity and specificity are too low to confirm or exclude sarcoidosis, and the diagnosis rests on tissue",
              "guideline_ids": [
                "GL-ATS-SARC-2020"
              ]
            },
            {
              "domain": "referral",
              "measure": "Pulmonology (sarcoidosis)",
              "cadence": "At diagnosis",
              "status": "completed_today",
              "detail": "Seen this morning; recommendations in the consultation note",
              "guideline_ids": [
                "GL-ATS-SARC-2020",
                "GL-ERS-SARC-2021"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9)",
              "cadence": "At diagnosis and at each phase of treatment",
              "status": "completed_today",
              "detail": "PHQ-9 6",
              "observation_ids": [
                "OBS-PHQ9-V2"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            }
          ],
          "follow_up": "Holter, echocardiogram, eye examination, cardiac MRI and FDG-PET within two weeks; review in two weeks to decide treatment. Call 911 for fainting, chest pain or a sustained racing heart",
          "guideline_ids": [
            "GL-ATS-SARC-2020",
            "GL-ERS-SARC-2021",
            "GL-HRS-CS-2014",
            "GL-AHA-CS-2024",
            "GL-BAUGHMAN-2016",
            "GL-MIRSAEIDI-2015",
            "GL-USPSTF-DEP-2023"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Cardiac MRI and FDG-PET results: cardiac sarcoidosis; start of prednisone and methotrexate, bone and infection protection, and electrophysiology referral",
        "status": "finished",
        "date": "2026-03-09",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Cardiac test results and the start of treatment",
          "hpi": {
            "narrative": "Ms. Jackson returns two weeks after the consultation with the results of her heart and eye tests. The Holter recorded first-degree atrioventricular block throughout, ectopic beats making up 6 percent of all beats, and three short runs of ventricular tachycardia, one during her palpitations. The echocardiogram and cardiac MRI show a mildly reduced pumping function (ejection fraction 47 percent) with scarring in the base of the septum and the side wall, and the FDG-PET three days ago shows active inflammation at the same sites. The eye examination was normal. Hepatitis B and C tests were negative, and she is not immune to hepatitis B. Cultures from the EBUS samples show no growth at three weeks. She is breathless on one flight of stairs, has had two more spells of palpitations, and has not fainted. She saw Dr. Asante-Miller and the cardiology team this morning. She asked whether she will sing again and was told that, with treatment, most people return to their work. She has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "Holter",
                "value": "PR 230 to 250 ms; ventricular ectopy 6 percent; three runs of nonsustained ventricular tachycardia up to 8 beats"
              },
              {
                "label": "Echocardiogram and MRI",
                "value": "Ejection fraction 47 percent; patchy enhancement of the basal anteroseptum and inferolateral wall"
              },
              {
                "label": "FDG-PET",
                "value": "Focal myocardial uptake matching the MRI; active hilar and mediastinal nodes"
              },
              {
                "label": "Eyes",
                "value": "No uveitis; normal pressures"
              },
              {
                "label": "Infection screening",
                "value": "Hepatitis B and C negative; not immune to hepatitis B; cultures no growth at three weeks"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired; no fever or weight loss"
            },
            {
              "system": "Respiratory",
              "status": "positive",
              "finding": "Breathless on one flight of stairs; dry cough"
            },
            {
              "system": "Cardiovascular",
              "status": "positive",
              "finding": "Two more spells of palpitations; no fainting, chest pain or ankle swelling"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No redness or blurred vision"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No thirst or frequent urination"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Frightened by the heart findings, steadied by her faith; PHQ-9 7; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 91.2 kg; blood pressure 124/78, pulse 80 with occasional ectopic beats"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation"
            },
            {
              "system": "Cardiovascular",
              "finding": "Occasional ectopic beats; no murmur, gallop or ankle swelling; jugular venous pressure normal"
            },
            {
              "system": "Mouth",
              "finding": "No thrush; teeth in good repair"
            },
            {
              "system": "Skin",
              "finding": "No rash or plaques"
            },
            {
              "system": "Psychiatric",
              "finding": "Thoughtful; asks about her voice and travel"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-005",
              "display": "Cardiac sarcoidosis",
              "assessment": "Cardiac sarcoidosis by the HRS criteria: sarcoidosis proven in lymph nodes, with unexplained first-degree atrioventricular block, nonsustained ventricular tachycardia, scar on MRI, matching active inflammation on PET and an ejection fraction of 47 percent. Active cardiac inflammation is treated with glucocorticoids and a steroid-sparing agent. The ejection fraction is above 35 percent, but the scar and nonsustained ventricular tachycardia make an electrophysiology study the next step to decide whether she needs a defibrillator. Dr. Asante-Miller and cardiology agree",
              "plan": [
                "Prednisone 40 mg each morning, with a taper planned over about six months",
                "Methotrexate 15 mg once weekly with folic acid 1 mg daily, increasing to 20 mg if tolerated",
                "Metoprolol succinate 25 mg daily",
                "Electrophysiology study next week, with a dual-chamber defibrillator if sustained ventricular tachycardia is induced",
                "Repeat FDG-PET after about five months of treatment"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Pulmonary sarcoidosis with lymph node involvement",
              "assessment": "The same treatment covers the lungs, where function is impaired and she has symptoms",
              "plan": [
                "Repeat lung function in about two months"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Long-term systemic glucocorticoid treatment",
              "assessment": "She will take prednisone for many months, with prediabetes (A1c 5.9%) and high calcium. Bone protection without calcium tablets while calcium is high; pneumocystis prophylaxis while prednisone is 20 mg or more with methotrexate, using atovaquone because trimethoprim-sulfamethoxazole adds to methotrexate's effect on the marrow; vaccines today, before immunosuppression takes hold",
              "plan": [
                "Bone density scan next week, then alendronate 70 mg weekly",
                "Atovaquone 1500 mg daily",
                "PCV20, the first recombinant zoster dose and the first hepatitis B dose today",
                "Home glucose checks twice a week; no alcohol on methotrexate"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Hypercalcemia",
              "assessment": "Calcium 10.6 mg/dL; expected to fall on prednisone",
              "plan": [
                "Calcium at the next visit"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Palpitations with conduction disease",
              "assessment": "Explained by cardiac sarcoidosis, diagnosed today; superseded",
              "plan": [
                "Problem resolved"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Holter monitoring",
              "cadence": "When the ECG is abnormal or there are palpitations",
              "status": "up_to_date",
              "detail": "Ventricular ectopy 6 percent; three runs of nonsustained ventricular tachycardia; first-degree block; no high-grade block",
              "guideline_ids": [
                "GL-HRS-CS-2014",
                "GL-AHA-CS-2024"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Echocardiogram and cardiac MRI",
              "cadence": "When cardiac involvement is suspected",
              "status": "up_to_date",
              "detail": "Ejection fraction 47 percent; late gadolinium enhancement about 9 percent of left ventricular mass",
              "guideline_ids": [
                "GL-HRS-CS-2014",
                "GL-AHA-CS-2024"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Cardiac FDG-PET",
              "cadence": "Before glucocorticoids, then three to six months into treatment",
              "status": "up_to_date",
              "detail": "Three days ago: active myocardial inflammation matching the MRI; repeat after about five months",
              "guideline_ids": [
                "GL-HRS-CS-2014",
                "GL-AHA-CS-2024"
              ]
            },
            {
              "domain": "examination",
              "measure": "Eye examination",
              "cadence": "At diagnosis, then yearly",
              "status": "up_to_date",
              "detail": "Five days ago: normal",
              "guideline_ids": [
                "GL-ATS-SARC-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Exclusion of other granulomatous causes",
              "cadence": "At diagnosis",
              "status": "ordered",
              "detail": "Cultures no growth at three weeks; final at six to eight weeks",
              "guideline_ids": [
                "GL-ATS-SARC-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Methotrexate safety: blood count, liver tests and creatinine",
              "cadence": "Before starting; every two to four weeks for the first three months; then every eight to twelve weeks",
              "status": "completed_today",
              "detail": "Baseline: hemoglobin 12.6 g/dL, white cells 4.8, lymphocytes 0.9, platelets 240; ALT 27, AST 29, alkaline phosphatase 124 U/L, albumin 4.0 g/dL; creatinine 1.02 mg/dL, eGFR 66",
              "observation_ids": [
                "OBS-HGB-V3",
                "OBS-WBC-V3",
                "OBS-LYM-V3",
                "OBS-PLT-V3",
                "OBS-ALT-V3",
                "OBS-AST-V3",
                "OBS-ALP-V3",
                "OBS-ALB-V3",
                "OBS-CR-V3",
                "OBS-EGFR-V3"
              ],
              "guideline_ids": [
                "GL-ACR-DMARD-2012",
                "GL-ERS-SARC-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis B and C screening",
              "cadence": "Before immunosuppressive treatment",
              "status": "up_to_date",
              "detail": "Negative; not immune to hepatitis B, so vaccination starts today",
              "guideline_ids": [
                "GL-ACR-DMARD-2012",
                "GL-ERS-SARC-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Serum calcium",
              "cadence": "At diagnosis, then at each treatment visit while it was raised or vitamin D is given",
              "status": "completed_today",
              "detail": "10.6 mg/dL",
              "observation_ids": [
                "OBS-CA-V3"
              ],
              "guideline_ids": [
                "GL-ATS-SARC-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Glucose before glucocorticoids",
              "cadence": "At the start, then at each visit",
              "status": "completed_today",
              "detail": "Glucose 101 mg/dL; A1c 5.9% at the first visit",
              "observation_ids": [
                "OBS-GLU-V3"
              ],
              "guideline_ids": [
                "GL-ACR-GIOP-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "NT-proBNP",
              "cadence": "At the cardiac diagnosis and when symptoms change",
              "status": "completed_today",
              "detail": "240 pg/mL",
              "observation_ids": [
                "OBS-BNP-V3"
              ],
              "guideline_ids": [
                "GL-HRS-CS-2014",
                "GL-AHA-CS-2024"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Bone density (DXA) and FRAX",
              "cadence": "At the start of glucocorticoids expected to last three months or more",
              "status": "ordered",
              "detail": "Booked for next week",
              "guideline_ids": [
                "GL-ACR-GIOP-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Pneumocystis prophylaxis",
              "cadence": "While prednisone is 20 mg or more with a second immunosuppressant",
              "status": "completed_today",
              "detail": "Atovaquone started; trimethoprim-sulfamethoxazole avoided with methotrexate",
              "guideline_ids": [
                "GL-ERS-SARC-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Vaccination before immunosuppression",
              "cadence": "Before or as treatment starts",
              "status": "completed_today",
              "detail": "PCV20, recombinant zoster dose 1 and hepatitis B dose 1 given today; influenza at the first visit; no live vaccines",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Cardiology and electrophysiology",
              "cadence": "When cardiac sarcoidosis is diagnosed",
              "status": "referred",
              "detail": "Seen with Dr. Asante-Miller today; electrophysiology study booked for next week",
              "guideline_ids": [
                "GL-HRS-CS-2014",
                "GL-AHA-CS-2024"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9)",
              "cadence": "At diagnosis and at each phase of treatment",
              "status": "completed_today",
              "detail": "PHQ-9 7",
              "observation_ids": [
                "OBS-PHQ9-V3"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            }
          ],
          "follow_up": "Bone density next week; electrophysiology study next week. No driving for a week after any device implant. Nine-week review with lung function and blood tests. Call 911 for fainting, a sustained racing heart or a defibrillator shock",
          "guideline_ids": [
            "GL-HRS-CS-2014",
            "GL-AHA-CS-2024",
            "GL-ERS-SARC-2021",
            "GL-ATS-SARC-2020",
            "GL-ACR-GIOP-2022",
            "GL-ACR-DMARD-2012",
            "GL-CDC-IMZ-2026",
            "GL-USPSTF-DEP-2023"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Nine weeks of treatment: lung function, calcium, methotrexate safety, the new defibrillator, steroid effects, and her concert schedule",
        "status": "finished",
        "date": "2026-05-11",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Review after nine weeks of treatment",
          "hpi": {
            "narrative": "Ms. Jackson returns nine weeks after starting prednisone and methotrexate. The electrophysiology study induced sustained ventricular tachycardia, and a dual-chamber defibrillator was placed the next day; the wound has healed and she has had no shocks. The remote transmission last week showed two short runs of ventricular tachycardia in March and none since. She climbs two flights before stopping, the cough has gone, and the palpitations are rare. She has had a large appetite, gained weight, and sleeps poorly on prednisone. Home glucose readings are 100 to 130 mg/dL. She has had no mouth sores, nausea or infections on methotrexate, and drinks no alcohol. The final EBUS cultures were negative. No methotrexate blood tests have been done since she started. She is eager to sing again and has concerts offered from the end of May. She has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "Device",
                "value": "Dual-chamber defibrillator since the electrophysiology study; no shocks; two runs of ventricular tachycardia in March, none since"
              },
              {
                "label": "Symptoms",
                "value": "Two flights of stairs; cough gone; palpitations rare"
              },
              {
                "label": "Steroid effects",
                "value": "Large appetite, weight up 2.8 kg, poor sleep; home glucose 100 to 130 mg/dL"
              },
              {
                "label": "Methotrexate",
                "value": "15 mg weekly; no mouth sores or nausea; no blood tests since starting"
              },
              {
                "label": "Work",
                "value": "Concerts offered from the end of May"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Large appetite; weight 94.0 kg; no fever"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "Cough gone; breathless only on the second flight"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "Palpitations rare; no shocks, fainting or ankle swelling"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No mouth sores or thrush; voice strong"
            },
            {
              "system": "Endocrine",
              "status": "positive",
              "finding": "Home glucose 100 to 130 mg/dL; no thirst"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Poor sleep on prednisone; mood good; PHQ-9 5; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 94.0 kg; blood pressure 138/86, pulse 66 and regular"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur; defibrillator pocket healed without swelling or tenderness"
            },
            {
              "system": "Mouth",
              "finding": "No thrush or ulcers"
            },
            {
              "system": "Skin",
              "finding": "Mild facial fullness; no bruising or infection"
            },
            {
              "system": "Psychiatric",
              "finding": "Cheerful, impatient to sing"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-005",
              "display": "Cardiac sarcoidosis on treatment, with a defibrillator",
              "assessment": "Clinically better: rare palpitations, no ventricular tachycardia since March, NT-proBNP 140 pg/mL from 240. The defibrillator protects her against sudden death while the inflammation settles",
              "plan": [
                "Prednisone taper: 30 mg daily for four weeks, then 20 mg for four weeks, 15 mg for four weeks, and 10 mg until the review in August",
                "Methotrexate increased to 20 mg once weekly",
                "Continue metoprolol; monthly remote device checks; clinic device check in three months",
                "Repeat FDG-PET and echocardiogram in mid-August"
              ]
            },
            {
              "problem_id": "PRB-006",
              "display": "Implantable cardioverter-defibrillator",
              "assessment": "Wound healed; she may drive again and lift her left arm fully. Singing and stage movement are safe; she should keep mobile phones and headphones 15 cm from the device and walk through airport security with her device card",
              "plan": [
                "Device card and travel letter given",
                "Remote monitor travels with her"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Pulmonary sarcoidosis",
              "assessment": "Lung function improving: FVC 84 percent from 74, DLCO 70 percent from 62",
              "plan": [
                "Repeat lung function in August"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Hypercalcemia",
              "assessment": "Calcium 9.6 mg/dL, normal on prednisone; resolved. Vitamin D can now be replaced cautiously: 25-hydroxyvitamin D 24 ng/mL",
              "plan": [
                "Cholecalciferol 1000 units daily, with calcium at the next visit",
                "Problem resolved"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Long-term systemic glucocorticoid treatment",
              "assessment": "Steroid effects: blood pressure 138/86, glucose 118 mg/dL and A1c 6.3% (from 5.9%), weight up 2.8 kg, poor sleep. Bone density in March showed moderate fracture risk; on alendronate since",
              "plan": [
                "Prednisone in the morning only; reduce salt and sweet drinks; walk daily",
                "Blood pressure at home twice a week; treat if it stays above 130/80 after the taper",
                "Stop atovaquone when prednisone falls below 20 mg"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "imaging",
              "measure": "Spirometry and diffusing capacity (FVC, FEV1, FEV1/FVC, DLCO)",
              "cadence": "At diagnosis, three months after starting treatment, then every three to six months while treatment changes",
              "status": "completed_today",
              "detail": "FVC 84 percent, FEV1 85 percent, FEV1/FVC 80 percent, DLCO 70 percent of predicted",
              "observation_ids": [
                "OBS-FVCP-V4",
                "OBS-FEV1P-V4",
                "OBS-RATIO-V4",
                "OBS-DLCOP-V4"
              ],
              "guideline_ids": [
                "GL-ATS-SARC-2020",
                "GL-ERS-SARC-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Methotrexate safety: blood count, liver tests and creatinine",
              "cadence": "Before starting; every two to four weeks for the first three months; then every eight to twelve weeks",
              "status": "deferred",
              "detail": "A deviation: the blood count, liver tests and creatinine due two to four weeks after methotrexate began were not done, because no laboratory order was placed for the long gap between visits. No harm resulted: today hemoglobin 13.1 g/dL, white cells 9.8 (raised by prednisone), lymphocytes 1.2, platelets 262, ALT 31, AST 28, alkaline phosphatase 96 U/L, albumin 4.1 g/dL, creatinine 0.92 mg/dL and eGFR 75 are normal. Corrective action: standing orders every four weeks until twelve weeks and then every eight to twelve weeks, at a laboratory near home or on tour, with a reminder to her and to the clinic",
              "observation_ids": [
                "OBS-HGB-V4",
                "OBS-WBC-V4",
                "OBS-LYM-V4",
                "OBS-PLT-V4",
                "OBS-ALT-V4",
                "OBS-AST-V4",
                "OBS-ALP-V4",
                "OBS-ALB-V4",
                "OBS-CR-V4",
                "OBS-EGFR-V4"
              ],
              "guideline_ids": [
                "GL-ACR-DMARD-2012",
                "GL-ERS-SARC-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Serum calcium",
              "cadence": "At diagnosis, then at each treatment visit while it was raised or vitamin D is given",
              "status": "completed_today",
              "detail": "9.6 mg/dL, normal",
              "observation_ids": [
                "OBS-CA-V4"
              ],
              "guideline_ids": [
                "GL-ATS-SARC-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Electrolytes",
              "cadence": "At each visit on glucocorticoids",
              "status": "completed_today",
              "detail": "Sodium 139, potassium 3.9 mmol/L",
              "observation_ids": [
                "OBS-NA-V4",
                "OBS-K-V4"
              ],
              "guideline_ids": [
                "GL-ACR-GIOP-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "25-hydroxyvitamin D",
              "cadence": "Before replacement and after it starts",
              "status": "completed_today",
              "detail": "24 ng/mL; replacement started now that calcium is normal",
              "observation_ids": [
                "OBS-VD25-V4"
              ],
              "guideline_ids": [
                "GL-ACR-GIOP-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Glucose and A1c on glucocorticoids",
              "cadence": "At each visit; A1c every three months",
              "status": "completed_today",
              "detail": "Glucose 118 mg/dL; A1c 6.3%",
              "observation_ids": [
                "OBS-GLU-V4",
                "OBS-A1C-V4"
              ],
              "guideline_ids": [
                "GL-ACR-GIOP-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "NT-proBNP",
              "cadence": "At each cardiac review",
              "status": "completed_today",
              "detail": "140 pg/mL",
              "observation_ids": [
                "OBS-BNP-V4"
              ],
              "guideline_ids": [
                "GL-HRS-CS-2014",
                "GL-AHA-CS-2024"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure and weight on glucocorticoids",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "138/86 mmHg; weight 94.0 kg, up 2.8 kg",
              "guideline_ids": [
                "GL-ACR-GIOP-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Bone density (DXA) and FRAX",
              "cadence": "At the start of long-term glucocorticoids, then every one to three years",
              "status": "up_to_date",
              "detail": "March: femoral neck T-score -1.6; moderate risk; alendronate",
              "guideline_ids": [
                "GL-ACR-GIOP-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Defibrillator check (remote and in clinic)",
              "cadence": "Remote transmissions monthly and with any symptom; clinic check every three to six months",
              "status": "completed_today",
              "detail": "Remote transmission last week: two runs of nonsustained ventricular tachycardia in March, none since; no therapies; normal lead values",
              "guideline_ids": [
                "GL-HRS-CS-2014",
                "GL-AHA-CS-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Exclusion of other granulomatous causes",
              "cadence": "At diagnosis",
              "status": "up_to_date",
              "detail": "Final mycobacterial and fungal cultures negative at eight weeks",
              "guideline_ids": [
                "GL-ATS-SARC-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Pneumocystis prophylaxis",
              "cadence": "While prednisone is 20 mg or more with a second immunosuppressant",
              "status": "completed_today",
              "detail": "Atovaquone continues until prednisone falls below 20 mg",
              "guideline_ids": [
                "GL-ERS-SARC-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Vaccination on immunosuppression",
              "cadence": "Per schedule",
              "status": "completed_today",
              "detail": "Hepatitis B dose 2 given today, completing the two-dose series; zoster dose 2 due in August",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9)",
              "cadence": "At diagnosis and at each phase of treatment",
              "status": "completed_today",
              "detail": "PHQ-9 5",
              "observation_ids": [
                "OBS-PHQ9-V4"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Performing and travel plan",
              "cadence": "At each visit",
              "status": "completed_today",
              "detail": "Two concerts a week in the United States from the end of May, with a rest day after each; no international touring until after the August PET; voice care; travel letter and device card",
              "guideline_ids": [
                "GL-ERS-SARC-2021",
                "GL-HRS-CS-2014",
                "GL-AHA-CS-2024"
              ]
            }
          ],
          "follow_up": "Methotrexate blood tests every four weeks. Remote device checks monthly. Review in mid-August after the repeat FDG-PET, echocardiogram and lung function. Call for fever, cough, breathlessness, a shock, or fainting",
          "guideline_ids": [
            "GL-ERS-SARC-2021",
            "GL-HRS-CS-2014",
            "GL-AHA-CS-2024",
            "GL-ACR-DMARD-2012",
            "GL-ACR-GIOP-2022",
            "GL-CMID-2026",
            "GL-CDC-IMZ-2026",
            "GL-USPSTF-DEP-2023"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Six months of treatment: repeat FDG-PET, steroid taper, and plans for touring",
        "status": "finished",
        "date": "2026-08-24",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Six-month review with the repeat FDG-PET",
          "hpi": {
            "narrative": "Ms. Jackson returns after about five and a half months of treatment. The repeat FDG-PET a week ago shows no remaining inflammation in the heart and much less in the lymph nodes, and the echocardiogram the same day shows an ejection fraction of 54 percent. She has taken prednisone 10 mg for three weeks and methotrexate 20 mg weekly. The laryngitis in June settled within ten days, and she has sung two concerts a week since late May without trouble. Her monthly methotrexate blood tests have been normal. The remote device checks show no ventricular tachycardia since March. She sleeps better on the lower dose and her appetite has settled. She would like to plan an autumn tour. She has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "FDG-PET and echocardiogram",
                "value": "No myocardial uptake; nodes smaller with low uptake; ejection fraction 54 percent from 47"
              },
              {
                "label": "Treatment",
                "value": "Prednisone 10 mg; methotrexate 20 mg weekly"
              },
              {
                "label": "Device",
                "value": "No ventricular tachycardia since March; no shocks"
              },
              {
                "label": "Work",
                "value": "Two concerts a week since late May; autumn tour proposed"
              },
              {
                "label": "Laryngitis",
                "value": "Resolved within ten days"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Energy good; weight 93.0 kg; no fever"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "Breathless only on hills; no cough"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No palpitations, shocks or fainting"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "Voice back to normal; no mouth sores"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No redness or blurred vision"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Sleeping better; PHQ-9 4; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 93.0 kg; blood pressure 130/82, pulse 64 and regular"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur; device pocket normal"
            },
            {
              "system": "Mouth",
              "finding": "No thrush or ulcers; voice clear"
            },
            {
              "system": "Skin",
              "finding": "No rash, plaques or bruising"
            },
            {
              "system": "Psychiatric",
              "finding": "Lively; planning her season"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-005",
              "display": "Cardiac sarcoidosis in remission on treatment",
              "assessment": "Myocardial inflammation has resolved on PET and the ejection fraction has improved to 54 percent. Cardiac sarcoidosis can relapse as glucocorticoids are tapered, so methotrexate continues for at least a year and the taper is slow. The defibrillator stays: the scar remains and the risk of ventricular tachycardia is lower but not gone",
              "plan": [
                "Prednisone 10 mg until late September, then 7.5 mg, and 5 mg from November if well",
                "Methotrexate 20 mg weekly for at least a year in all",
                "Repeat FDG-PET about three months after reaching 5 mg, or sooner for palpitations or shocks",
                "Clinic device check this month; remote checks monthly"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Pulmonary sarcoidosis",
              "assessment": "Lung function further improved: FVC 90 percent and DLCO 76 percent of predicted",
              "plan": [
                "Lung function every three to six months while the treatment changes"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Long-term systemic glucocorticoid treatment",
              "assessment": "Blood pressure 130/82, glucose 108 mg/dL and A1c 6.2%, weight down 1 kg as the dose falls. Calcium 9.5 mg/dL and 25-hydroxyvitamin D 34 ng/mL on 1000 units daily. Atovaquone was stopped in July when prednisone fell below 20 mg",
              "plan": [
                "Second recombinant zoster dose today",
                "Continue alendronate and cholecalciferol",
                "Eye examination with pressure check in March, one year after the first"
              ]
            },
            {
              "problem_id": "PRB-008",
              "display": "Acute viral laryngitis",
              "assessment": "Resolved within ten days without antibiotics",
              "plan": [
                "Problem resolved"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "imaging",
              "measure": "Cardiac FDG-PET",
              "cadence": "Three to six months into treatment, and after major dose changes",
              "status": "up_to_date",
              "detail": "A week ago: no myocardial uptake; nodes smaller with low uptake",
              "guideline_ids": [
                "GL-HRS-CS-2014",
                "GL-AHA-CS-2024"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Echocardiogram",
              "cadence": "With the repeat PET, and for symptoms",
              "status": "up_to_date",
              "detail": "A week ago: ejection fraction 54 percent",
              "guideline_ids": [
                "GL-HRS-CS-2014",
                "GL-AHA-CS-2024"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Spirometry and diffusing capacity (FVC, FEV1, FEV1/FVC, DLCO)",
              "cadence": "At diagnosis, three months after starting treatment, then every three to six months while treatment changes",
              "status": "completed_today",
              "detail": "FVC 90 percent, FEV1 89 percent, FEV1/FVC 79 percent, DLCO 76 percent of predicted",
              "observation_ids": [
                "OBS-FVCP-V5",
                "OBS-FEV1P-V5",
                "OBS-RATIO-V5",
                "OBS-DLCOP-V5"
              ],
              "guideline_ids": [
                "GL-ATS-SARC-2020",
                "GL-ERS-SARC-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Methotrexate safety: blood count, liver tests and creatinine",
              "cadence": "Before starting; every two to four weeks for the first three months; then every eight to twelve weeks",
              "status": "completed_today",
              "detail": "Hemoglobin 13.0 g/dL, white cells 8.1, lymphocytes 1.4, platelets 248; ALT 29, AST 27, alkaline phosphatase 90 U/L, albumin 4.1 g/dL; creatinine 0.90 mg/dL, eGFR 77; the monthly tests since May were normal; now every eight to twelve weeks",
              "observation_ids": [
                "OBS-HGB-V5",
                "OBS-WBC-V5",
                "OBS-LYM-V5",
                "OBS-PLT-V5",
                "OBS-ALT-V5",
                "OBS-AST-V5",
                "OBS-ALP-V5",
                "OBS-ALB-V5",
                "OBS-CR-V5",
                "OBS-EGFR-V5"
              ],
              "guideline_ids": [
                "GL-ACR-DMARD-2012",
                "GL-ERS-SARC-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Serum calcium",
              "cadence": "At diagnosis, then at each treatment visit while it was raised or vitamin D is given",
              "status": "completed_today",
              "detail": "9.5 mg/dL on cholecalciferol",
              "observation_ids": [
                "OBS-CA-V5"
              ],
              "guideline_ids": [
                "GL-ATS-SARC-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "25-hydroxyvitamin D",
              "cadence": "After replacement starts",
              "status": "completed_today",
              "detail": "34 ng/mL",
              "observation_ids": [
                "OBS-VD25-V5"
              ],
              "guideline_ids": [
                "GL-ACR-GIOP-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Glucose and A1c on glucocorticoids",
              "cadence": "At each visit; A1c every three months",
              "status": "completed_today",
              "detail": "Glucose 108 mg/dL; A1c 6.2%",
              "observation_ids": [
                "OBS-GLU-V5",
                "OBS-A1C-V5"
              ],
              "guideline_ids": [
                "GL-ACR-GIOP-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "NT-proBNP",
              "cadence": "At each cardiac review",
              "status": "completed_today",
              "detail": "96 pg/mL, normal",
              "observation_ids": [
                "OBS-BNP-V5"
              ],
              "guideline_ids": [
                "GL-HRS-CS-2014",
                "GL-AHA-CS-2024"
              ]
            },
            {
              "domain": "examination",
              "measure": "Defibrillator check (remote and in clinic)",
              "cadence": "Remote transmissions monthly and with any symptom; clinic check every three to six months",
              "status": "completed_today",
              "detail": "Remote transmissions monthly: no ventricular tachycardia since March; clinic check booked this month",
              "guideline_ids": [
                "GL-HRS-CS-2014",
                "GL-AHA-CS-2024"
              ]
            },
            {
              "domain": "examination",
              "measure": "Eye examination",
              "cadence": "Yearly with sarcoidosis and on glucocorticoids",
              "status": "up_to_date",
              "detail": "Normal in March; next due in March",
              "guideline_ids": [
                "GL-ATS-SARC-2020"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Bone density (DXA)",
              "cadence": "Every one to three years on glucocorticoids",
              "status": "up_to_date",
              "detail": "March; repeat in two years",
              "guideline_ids": [
                "GL-ACR-GIOP-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Pneumocystis prophylaxis",
              "cadence": "While prednisone is 20 mg or more with a second immunosuppressant",
              "status": "not_indicated",
              "detail": "Stopped in July when prednisone fell below 20 mg",
              "guideline_ids": [
                "GL-ERS-SARC-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Vaccination on immunosuppression",
              "cadence": "Per schedule",
              "status": "completed_today",
              "detail": "Recombinant zoster dose 2 given today; influenza and COVID-19 due in the autumn",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9)",
              "cadence": "At diagnosis and at each phase of treatment",
              "status": "completed_today",
              "detail": "PHQ-9 4",
              "observation_ids": [
                "OBS-PHQ9-V5"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Performing and travel plan",
              "cadence": "At each visit",
              "status": "completed_today",
              "detail": "Autumn tour in the United States approved with rest days and the same medicine and device plan; a tour abroad next spring to be decided after the next review",
              "guideline_ids": [
                "GL-ERS-SARC-2021",
                "GL-HRS-CS-2014",
                "GL-AHA-CS-2024"
              ]
            }
          ],
          "follow_up": "Clinic device check this month. Methotrexate blood tests every eight to twelve weeks. Preventive visit in about six weeks with influenza and COVID-19 vaccines. Pulmonology review in three months",
          "guideline_ids": [
            "GL-AHA-CS-2024",
            "GL-HRS-CS-2014",
            "GL-ERS-SARC-2021",
            "GL-ATS-SARC-2020",
            "GL-ACR-DMARD-2012",
            "GL-ACR-GIOP-2022",
            "GL-CDC-IMZ-2026",
            "GL-USPSTF-DEP-2023"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Same-day sick visit for laryngitis on immunosuppressive treatment",
        "status": "finished",
        "date": "2026-06-15",
        "visit_type": "sick",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "185345009",
          "display": "Encounter for symptom",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Hoarse voice and sore throat for three days, with a concert in four days",
          "billing_note": "Problem-oriented office visit, established patient",
          "hpi": {
            "narrative": "Ms. Jackson called on Monday and was seen the same day. A cold began five days ago, after a weekend of two concerts and a church service; for three days her voice has been hoarse and breaks on high notes, her throat is sore, and she has a mild dry cough. Her highest temperature at home was 37.5 °C. She has no breathlessness beyond her usual, no chest pain, no palpitations, and no shocks from her defibrillator. She takes prednisone 20 mg each morning, methotrexate 20 mg on Sundays with folic acid daily, atovaquone, metoprolol, alendronate and vitamin D, and has missed no doses. She has a concert on Friday and is worried about singing through it. She has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "Onset",
                "value": "Cold five days ago; hoarseness for three days"
              },
              {
                "label": "Voice",
                "value": "Hoarse; breaks on high notes; speaking voice tires by evening"
              },
              {
                "label": "Temperature",
                "value": "Highest 37.5 °C at home; 37.4 °C today"
              },
              {
                "label": "Context",
                "value": "On prednisone 20 mg daily and methotrexate 20 mg weekly; a concert in four days"
              },
              {
                "label": "Associated signs and symptoms",
                "value": "Sore throat and dry cough; no breathlessness beyond her usual, chest pain, palpitations, device shocks, or thoughts of self-harm"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever of 38.0 °C or more, chills or night sweats"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "positive",
              "finding": "Hoarseness, sore throat and a runny nose; no mouth sores, white patches or ear pain"
            },
            {
              "system": "Respiratory",
              "status": "positive",
              "finding": "Mild dry cough; breathing no worse than her usual; no wheeze"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations or device shocks"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Worried about the concert; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; hoarse, breathy voice; temperature 37.4 °C, pulse 72, blood pressure 134/84, oxygen saturation 97 percent on room air"
            },
            {
              "system": "Head, eyes, ears, nose, and throat",
              "finding": "Mildly red throat without exudate; no thrush on the tongue, palate or throat; clear nasal discharge; ear drums normal"
            },
            {
              "system": "Neck",
              "finding": "No tender or enlarged nodes; no stridor"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation; no crackles or wheeze"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; defibrillator pocket healed"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-008",
              "display": "Acute viral laryngitis",
              "assessment": "Laryngitis after a viral cold, in a singer who has been singing hard; rapid influenza and COVID-19 tests are negative, there is no fever, the chest is clear and there is no thrush, so this needs no antibiotic and no change in her sarcoidosis treatment. Laryngeal sarcoidosis is possible but unlikely with a short illness after a cold; if the hoarseness lasts more than four weeks she needs laryngoscopy, as the hoarseness guideline advises. Singing on an inflamed larynx risks vocal fold injury, and she agreed to postpone Friday's concert",
              "plan": [
                "Voice rest for five days: no singing and quiet speech only; no whispering",
                "Warm fluids, steam inhalation and humidified air; throat lozenges",
                "Postpone Friday's concert; a letter for the promoter, with her consent, giving no medical details",
                "Continue prednisone 20 mg, methotrexate and atovaquone; call at once for fever of 38.0 °C or more, breathlessness or chest pain, because she is immunosuppressed",
                "Laryngoscopy with an ear, nose and throat specialist if the hoarseness lasts beyond four weeks"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Cardiac sarcoidosis with a defibrillator",
              "assessment": "No palpitations or shocks; regular rhythm",
              "plan": [
                "Continue metoprolol and remote monitoring"
              ]
            }
          ],
          "follow_up": "Phone check in three days. Return if hoarseness lasts beyond four weeks or for fever, breathlessness or chest pain. Next planned review in August with the repeat FDG-PET",
          "guideline_ids": [
            "GL-AAO-HNS-HOARSE-2018",
            "GL-ERS-SARC-2021"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic unscheduled sick visit; the infection is not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "ENC-007",
        "display": "Periodic adult preventive visit",
        "status": "finished",
        "date": "2026-10-05",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Periodic adult preventive visit",
          "billing_note": "CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning) on the same day",
          "health_risk_assessment_method": "Completed on paper in the waiting room and reviewed with her by Dr. Fontenot",
          "hpi": {
            "narrative": "Ms. Jackson, 52, comes for her yearly preventive visit six weeks after the review at which the repeat FDG-PET showed no active heart inflammation. Prednisone was reduced to 7.5 mg two weeks ago as planned; she takes methotrexate 20 mg weekly with folic acid, metoprolol, alendronate and vitamin D. She has more energy, climbs two flights of stairs without stopping, and has sung two concerts a week since the spring, with a longer tour planned for later in the autumn. The hoarseness in June settled within ten days. Her defibrillator has given no shocks, and the remote check last month was normal. She sleeps well now that the prednisone dose is lower. Her PHQ-9 today is 3.",
            "elements": [
              {
                "label": "Visit",
                "value": "Periodic adult preventive visit, age 52"
              },
              {
                "label": "Active conditions",
                "value": "Pulmonary and cardiac sarcoidosis in remission on treatment; dual-chamber defibrillator; long-term glucocorticoids"
              },
              {
                "label": "Medicines",
                "value": "Prednisone 7.5 mg daily; methotrexate 20 mg weekly with folic acid 1 mg daily; metoprolol succinate 25 mg; alendronate 70 mg weekly; cholecalciferol 1000 units daily"
              },
              {
                "label": "Mood",
                "value": "PHQ-9 3"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Good, and much better than in the winter"
            },
            {
              "domain": "Psychosocial",
              "finding": "Faith and her church community are her strength; touring is tiring but is her purpose; worried about money while concerts were cancelled"
            },
            {
              "domain": "Tobacco",
              "finding": "Never smoked"
            },
            {
              "domain": "Alcohol and drugs",
              "finding": "No alcohol (she avoids it on methotrexate) and no drugs"
            },
            {
              "domain": "Physical activity",
              "finding": "Walks 30 minutes most days at home; less on tour"
            },
            {
              "domain": "Nutrition",
              "finding": "Home cooking at home; irregular meals on tour; has cut down on sweet drinks since her A1c rose; no calcium tablets, dairy twice a day"
            },
            {
              "domain": "Sleep",
              "finding": "Seven hours since the prednisone was lowered"
            },
            {
              "domain": "Safety at home",
              "finding": "Feels safe; no one hurts, threatens or controls her"
            },
            {
              "domain": "Road safety",
              "finding": "Wears a seat belt; driven on tour"
            },
            {
              "domain": "Falls",
              "finding": "No falls"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Energy better; no fever, night sweats or weight change"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No redness, pain, blurred vision or floaters"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "Voice back to normal; no mouth sores"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations, fainting or device shocks"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "Breathless only on hills; no cough"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No heartburn with alendronate; no change in bowel habit or blood"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary symptoms or vaginal bleeding"
            },
            {
              "system": "Breast",
              "status": "negative",
              "finding": "No lump, skin change or nipple discharge"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No bone pain or joint swelling"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash, nodules or skin plaques; easy bruising less now"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No numbness, weakness or headache"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No thirst or frequent urination"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-9 3; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well; weight 92.2 kg, BMI 31.9; blood pressure 128/80 (average of two)"
            },
            {
              "system": "Eyes",
              "finding": "No redness; pupils equal and reactive"
            },
            {
              "system": "Head, eyes, ears, nose, and throat",
              "finding": "No thrush; voice clear"
            },
            {
              "system": "Neck",
              "finding": "No lymph nodes; thyroid normal"
            },
            {
              "system": "Breasts",
              "finding": "Examined with her agreement and a chaperone: no mass, skin change or nipple discharge; no axillary nodes"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur; defibrillator pocket healed; no ankle swelling"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation bilaterally"
            },
            {
              "system": "Abdomen",
              "finding": "Old lower midline scar; soft; no liver or spleen enlargement"
            },
            {
              "system": "Pelvic",
              "finding": "Speculum examination with her agreement and a chaperone: vaginal cuff healed, no cervix present"
            },
            {
              "system": "Skin",
              "finding": "No rash, nodules or plaques; no suspicious lesions"
            },
            {
              "system": "Musculoskeletal",
              "finding": "Height 170 cm, unchanged; no spinal tenderness"
            },
            {
              "system": "Psychiatric",
              "finding": "Warm, lively, engaged"
            }
          ],
          "assessment_plan": [
            {
              "display": "Periodic adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and the prevention plan updated for a woman of 52 on long-term glucocorticoids and methotrexate. Total cholesterol 204, HDL 54, LDL 126 mg/dL, triglycerides 118; her ten-year cardiovascular risk is about 4 percent, so a statin is not recommended now, with lifestyle advice and a recheck in a year. A1c 6.2% in August is in the prediabetes range, partly from prednisone; a diabetes prevention program was offered. Mammography is due. Colonoscopy six years ago was normal. Cervical screening is not needed: the examination today shows no cervix after her hysterectomy, and she has no history of cervical precancer. Influenza and COVID-19 vaccines given today; her pneumococcal, zoster and hepatitis B series are complete; no live vaccines on her current treatment",
              "plan": [
                "Influenza and COVID-19 vaccines given today",
                "Screening mammogram ordered",
                "Diabetes prevention program referral",
                "Lipids and A1c again in one year, or sooner if prednisone is increased",
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Cardiac sarcoidosis in remission on treatment, with a defibrillator",
              "assessment": "No palpitations or shocks; regular rhythm; remote device check last month normal",
              "plan": [
                "Continue the prednisone taper as planned by Dr. Asante-Miller and cardiology",
                "Continue methotrexate 20 mg weekly",
                "Methotrexate safety blood tests next month"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Long-term systemic glucocorticoids",
              "assessment": "Bone density in March showed a femoral neck T-score of -1.6 on starting prednisone; on alendronate, with dietary calcium and vitamin D 1000 units, and calcium normal",
              "plan": [
                "Continue alendronate while on prednisone",
                "Repeat bone density scan two years after the first",
                "Eye examination with pressure check in March, one year after the first"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Blood pressure screening",
              "status": "completed_today",
              "detail": "128/80 mmHg, lower than on high-dose prednisone",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-9 score 3; item 9 scored 0",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "service": "Unhealthy alcohol use screening",
              "status": "completed_today",
              "detail": "No alcohol",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Tobacco use",
              "status": "completed_today",
              "detail": "Never smoked",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Intimate partner violence screening",
              "status": "completed_today",
              "detail": "Negative; she feels safe",
              "guideline_ids": [
                "GL-USPSTF-IPV-2018"
              ]
            },
            {
              "service": "Breast cancer screening",
              "status": "ordered",
              "detail": "Mammogram every two years from 40; last one three years ago; ordered today",
              "guideline_ids": [
                "GL-USPSTF-BREAST-2024"
              ]
            },
            {
              "service": "Colorectal cancer screening",
              "status": "up_to_date",
              "detail": "Colonoscopy six years ago normal; next due in four years",
              "guideline_ids": [
                "GL-USPSTF-CRC-2021"
              ]
            },
            {
              "service": "Cervical cancer screening",
              "status": "not_indicated",
              "detail": "No cervix on examination today after hysterectomy, and no history of cervical precancer",
              "guideline_ids": [
                "GL-USPSTF-CERV-2018"
              ]
            },
            {
              "service": "Diabetes screening",
              "status": "completed_today",
              "detail": "A1c 6.2% in August: prediabetes; diabetes prevention program offered",
              "guideline_ids": [
                "GL-USPSTF-DM-2021"
              ]
            },
            {
              "service": "Cholesterol screening and statin decision",
              "status": "completed_today",
              "detail": "Total cholesterol 204, HDL 54, LDL 126 mg/dL; ten-year risk about 4 percent; no statin now",
              "guideline_ids": [
                "GL-USPSTF-STATIN-2022"
              ]
            },
            {
              "service": "Osteoporosis screening and glucocorticoid bone protection",
              "status": "up_to_date",
              "detail": "Bone density in March, T-score -1.6; on alendronate; repeat in two years",
              "guideline_ids": [
                "GL-ACR-GIOP-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "service": "HIV and hepatitis C screening",
              "status": "up_to_date",
              "detail": "Both negative at the consultation in February",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Influenza vaccine",
              "status": "completed_today",
              "detail": "Inactivated vaccine given",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "COVID-19 vaccine",
              "status": "completed_today",
              "detail": "This season's mRNA vaccine given",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Pneumococcal vaccine",
              "status": "up_to_date",
              "detail": "PCV20 in March, before immunosuppression",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Recombinant zoster vaccine",
              "status": "up_to_date",
              "detail": "Two doses, March and August",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Hepatitis B vaccine",
              "status": "up_to_date",
              "detail": "Two-dose adjuvanted series completed in May",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Tetanus, diphtheria, and pertussis",
              "status": "up_to_date",
              "detail": "Tdap six years ago",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Live vaccines (MMR, varicella)",
              "status": "not_indicated",
              "detail": "Avoided on prednisone and methotrexate",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Eye examination",
              "status": "up_to_date",
              "detail": "Ophthalmology in March normal (no uveitis); yearly while on glucocorticoids and with sarcoidosis",
              "guideline_ids": [
                "GL-ATS-SARC-2020"
              ]
            },
            {
              "service": "Dental examination",
              "status": "due",
              "detail": "Before the autumn tour; alendronate noted for the dentist",
              "guideline_ids": [
                "GL-PREV-2026"
              ]
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 30 minutes, with her consent. She named a health care agent, recorded in the confidential part of the chart and not named here, and completed a health care power of attorney. She said that her faith guides her, that she wants every treatment that gives her a good chance to live and to sing, and that if she became so ill that she could not recover to know and pray with the people around her, she would want comfort care and her church's prayers rather than machines. The defibrillator was explained: it can be switched off painlessly by the device team if she ever chooses comfort care at the end of life, and she asked that this be discussed with her agent then. To be revisited at each change in her health and at least yearly.",
          "follow_up": "Mammogram within the month. Methotrexate blood tests next month. Pulmonology and cardiology as planned. Next preventive visit in one year",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-CDC-IMZ-2026",
            "GL-USPSTF-BREAST-2024",
            "GL-USPSTF-STATIN-2022",
            "GL-ACR-GIOP-2022",
            "GL-HRS-CS-2014"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic periodic preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-02-09",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 170,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 92.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 31.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 128,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 80,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 86,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 18,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.8,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 95,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at presentation; pulse irregular with ectopic beats. No measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-02-23",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 170,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 91.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 31.7,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 126,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 82,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 18,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 95,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-03-09",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 170,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 91.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 31.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 124,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 80,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 18,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 95,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-05-11",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 170,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 94.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 32.5,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 138,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 86,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 66,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs on prednisone and metoprolol; blood pressure higher than at baseline.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-08-24",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 170,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 93.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 32.2,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 130,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 82,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 64,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-06-15",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 170,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 93.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 32.3,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 134,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 84,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.4,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at the sick visit; no fever.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "VSET-007",
        "date": "2026-10-05",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 170,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 92.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 31.9,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 128,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 80,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 66,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the preventive visit, average of two readings.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Gospel singer who tours in the United States and abroad, with concerts of two to three hours several times a week, recording sessions, and singing at her church in Chicago; travels by car and air; reads no music and sings by ear",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic modern work history anchored to her documented career.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Lives in her own house on the South Side of Chicago; has no children; an extended family and a large church community; travels with her pianist and a small company. No relative, companion or colleague is named or given a role in her care",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0001",
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic household anchored to the documented accounts of her life; no real person is given a role.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Has known racism on the road and at home; long drives between concerts, irregular meals, and little rest on tour; wants her doctors to understand that singing is her calling and her living",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic social history anchored to her documented experience of touring in segregation and of violence at her home.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Never smoker; no alcohol; no drug use; faith central to her life",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic substance history for the modern episode; her real habits were not researched and are not used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Hysterectomy at 40; no periods since; no menopausal hormone therapy",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic reproductive history anchored to the documented hysterectomy.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent; climbs one flight of stairs before stopping for breath; has shortened her concerts by half an hour",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic functional status at presentation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Warm, forthright and tired; worried that she will have to stop singing; PHQ-2 negative; no thoughts of self-harm",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about her real mental state.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "Suspected sarcoidosis in a 52-year-old gospel singer with three months of exertional breathlessness, dry cough, tiredness and chest tightness, bilateral hilar lymphadenopathy with upper-zone reticulonodular opacities on today's chest radiograph, a calcium of 10.8 mg/dL, lymphopenia, and palpitations with first-degree atrioventricular block and frequent ventricular ectopy on ECG. Granulomas were reported at an abdominal operation twelve years ago; no pathology report is available. Please see her within two weeks, obtain tissue, and advise on cardiac evaluation and treatment",
        "urgency": "Urgent, within two weeks; tissue sampling can be arranged before the visit",
        "pertinent_history": "Three months of breathlessness on one flight of stairs and on stage, a dry cough, tiredness, and tightness in the chest; she cannot hold long phrases and has shortened her concerts. Two spells of palpitations with light-headedness while singing; no fainting. At 40, after a concert tour abroad during which she was breathless and had abdominal cramps, she had a hysterectomy, and granulomas were reported in her abdomen; she was told she had sarcoidosis. Takes an over-the-counter calcium and vitamin D tablet, stopped today; no other medicines; no known allergies. Never smoker; no alcohol; no known exposure to birds, mold, metals or tuberculosis. Examination: oxygen saturation 95 percent, irregular pulse with ectopic beats, clear chest, no rash, no palpable nodes. Results today: chest radiograph as above; ECG PR 240 ms with ventricular ectopics; hemoglobin 12.4 g/dL, lymphocytes 0.9; calcium 10.8 mg/dL; creatinine 1.08 mg/dL; alkaline phosphatase 128 U/L; 25-hydroxyvitamin D 22 ng/mL and 1,25-dihydroxyvitamin D 84 pg/mL; NT-proBNP 210 pg/mL; TSH 1.8; A1c 5.9%. Interferon-gamma release assay and HIV test sent; CT of the chest booked this week. She tours and records for her living and wants a plan she can keep",
        "questions": [
          "Is this sarcoidosis, and what is needed to confirm it and exclude tuberculosis, fungal infection and lymphoma?",
          "Which other organs should be screened, and how should her high calcium and vitamin D be handled?",
          "Does she have cardiac sarcoidosis, and what tests should be done, and in what order relative to any treatment?",
          "Does she need treatment, and with what, including a steroid-sparing agent?",
          "What is her risk of dangerous heart rhythms, and does she need a defibrillator or pacemaker?",
          "How should treatment be monitored and its side effects prevented, and how can she keep singing and touring?"
        ]
      },
      "consultant_note": {
        "history": "Ms. Jackson, 52, is seen at the request of Dr. Fontenot two weeks after she presented with three months of exertional breathlessness, dry cough, tiredness and palpitations. A CT of the chest two days later showed symmetric hilar and mediastinal adenopathy with perilymphatic upper-lobe nodules, and I performed EBUS-guided needle aspiration five days ago. She had a hysterectomy at 40, when granulomas were reported in her abdomen; no report survives. She stopped her calcium and vitamin D tablet two weeks ago. She has had one more spell of palpitations while singing; no fainting. She has postponed three weeks of concerts. She has no eye symptoms and no rash. Never smoker; no relevant exposures",
        "data_reviewed": "Dr. Fontenot's intake note and results. Chest radiograph: bilateral hilar adenopathy with upper-zone reticulonodular opacities (Scadding stage II). High-resolution CT: hilar, subcarinal and right paratracheal nodes up to 2.4 cm with fine calcification; perilymphatic micronodules in both upper lobes; no fibrosis. EBUS-guided aspiration of stations 4R, 7 and 11L: non-necrotizing granulomas; acid-fast and fungal stains negative; cultures pending; lavage lymphocytes 32 percent with a CD4 to CD8 ratio of 5.2. Interferon-gamma release assay and HIV negative. ECG: sinus rhythm, PR 240 ms, frequent unifocal ventricular ectopy. Pulmonary function today: FVC 74 percent, FEV1 76 percent, FEV1/FVC 80 percent, total lung capacity 78 percent, DLCO 62 percent of predicted. Calcium 10.7 mg/dL today off the supplement (10.8 at the first visit); creatinine 1.04 mg/dL; 25-hydroxyvitamin D 22 ng/mL; 1,25-dihydroxyvitamin D 84 pg/mL; alkaline phosphatase 128 U/L; lymphocytes 0.9; NT-proBNP 210 pg/mL",
        "exam": [
          {
            "system": "General",
            "finding": "Well; weight 91.6 kg; blood pressure 126/78, pulse 82 and irregular with ectopic beats; oxygen saturation 95 percent on room air"
          },
          {
            "system": "Respiratory",
            "finding": "Clear to auscultation; no crackles or clubbing"
          },
          {
            "system": "Cardiovascular",
            "finding": "Occasional ectopic beats; no murmur; no ankle swelling"
          },
          {
            "system": "Skin",
            "finding": "No erythema nodosum, lupus pernio, plaques or scar infiltration"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-004",
            "display": "Pulmonary sarcoidosis with lymph node involvement",
            "assessment": "Sarcoidosis is confirmed to the standard the ATS guideline asks: a compatible clinical and radiologic picture, non-necrotizing granulomas in lymph nodes obtained by EBUS rather than mediastinoscopy, and no evidence so far of tuberculosis, fungal infection or lymphoma, with final cultures to follow. The lavage lymphocytosis with a high CD4 to CD8 ratio supports it. It is Scadding stage II, with mild restriction and a reduced DLCO, and she is symptomatic. The granulomas reported at her abdominal operation are consistent with long-standing disease. Sarcoidosis is more common in Black women in the United States and carries a higher risk of severe and fatal disease, so a complete organ screen matters. Serum ACE adds nothing to the diagnosis and is not needed"
          },
          {
            "problem_id": "PRB-003",
            "display": "Hypercalcemia",
            "assessment": "Granulomas convert vitamin D to its active form, as the high 1,25-dihydroxyvitamin D with a low 25-hydroxyvitamin D shows. The supplement made it worse. No calcium or vitamin D supplements until the calcium is normal on treatment; then vitamin D may be replaced cautiously with calcium checks. Bone protection on glucocorticoids should use a bisphosphonate, not calcium tablets"
          },
          {
            "problem_id": "PRB-002",
            "display": "Palpitations with first-degree atrioventricular block and ventricular ectopy",
            "assessment": "Unexplained conduction disease and ventricular ectopy in a patient with proven extracardiac sarcoidosis means cardiac sarcoidosis must be excluded. The HRS consensus and the AHA statement advise Holter monitoring, an echocardiogram, cardiac MRI with late gadolinium enhancement and cardiac FDG-PET. The PET must be done before any glucocorticoid, which would mask active inflammation, and needs a 72-hour high-fat, very-low-carbohydrate preparation"
          }
        ],
        "recommendations": [
          "Complete the screen for other organ involvement: ophthalmology examination now and yearly; calcium, creatinine and liver tests at each visit; the ECG is done",
          "Cardiac evaluation within two weeks and before any treatment: 24-hour Holter, echocardiogram, cardiac MRI with late gadolinium enhancement, and cardiac FDG-PET with dietary preparation; joint review with cardiology",
          "If cardiac sarcoidosis is confirmed: prednisone 40 mg daily for about two months, then a slow taper over about six months toward 5 to 10 mg, with methotrexate 15 mg weekly rising to 20 mg and folic acid, continued for at least a year; if the heart is not involved, the same steroid-sparing approach for symptomatic stage II disease with impaired lung function, at a lower prednisone dose",
          "If cardiac sarcoidosis is confirmed with an ejection fraction above 35 percent, an electrophysiology study, and a dual-chamber defibrillator if sustained ventricular tachycardia is induced, given the conduction disease; a beta-blocker for the ventricular ectopy",
          "Before immunosuppression: hepatitis B and C serology (drawn today), tuberculosis already excluded by the interferon-gamma release assay, and PCV20, recombinant zoster and, if non-immune, hepatitis B vaccines; no live vaccines on treatment",
          "On treatment: pneumocystis prophylaxis with atovaquone while prednisone is 20 mg or more with methotrexate, avoiding trimethoprim-sulfamethoxazole; a bone density scan and a bisphosphonate; glucose, blood pressure, weight, sleep and mood checks; methotrexate blood tests every two to four weeks for three months, then every eight to twelve weeks; no alcohol",
          "Response assessment: lung function about two months after starting and then every three to six months; repeat cardiac FDG-PET three to six months into treatment",
          "Performing and travel: postpone concerts until the cardiac tests and any device implant are done, then resume a lighter schedule with rest days; voice care; carry a medicine list and any device card when travelling"
        ],
        "communication": "Discussed with Dr. Fontenot the same day and with cardiology. The diagnosis and the reasons for testing her heart before starting prednisone were explained to Ms. Jackson, who agreed to the plan and to postponing her concerts for now. She decides who else receives this note",
        "follow_up": "Holter tomorrow; echocardiogram, eye examination, cardiac MRI and FDG-PET within two weeks; joint review with Dr. Fontenot and cardiology in two weeks to decide treatment; pulmonology review with lung function about two months after treatment starts"
      },
      "guideline_ids": [
        "GL-ATS-SARC-2020",
        "GL-ERS-SARC-2021",
        "GL-HRS-CS-2014",
        "GL-AHA-CS-2024",
        "GL-ACR-GIOP-2022",
        "GL-ACR-DMARD-2012",
        "GL-CDC-IMZ-2026",
        "GL-BAUGHMAN-2016",
        "GL-MIRSAEIDI-2015"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "Short of breath on stairs and on stage for about three months, with a dry cough, tiredness and tightness in the chest; she runs out of breath in the middle of long phrases; twice her heart has raced and she felt faint while singing",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic presenting concern anchored to the documented breathlessness during performances.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "She was told after an operation twelve years ago that she had sarcoidosis; no record of that operation is available to this clinic, and she wants a clear answer and a plan that a working singer can keep",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic patient-centered concern anchored to the documented diagnosis after the operation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "HC-003",
        "display": "Her spring concerts and recording sessions are booked; she does not want to cancel unless she has to, and she needs her voice",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic concern anchored to her documented touring.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Tissue diagnosis with other causes excluded, and screening of the eyes, heart, calcium, liver and kidneys, within four weeks of presentation",
        "status": "completed",
        "target_date": "2026-03-09",
        "outcome": "EBUS in nine days; eye examination, Holter, echocardiogram, cardiac MRI and FDG-PET within four weeks",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diagnostic-pathway goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "Calcium in the normal range within three months",
        "status": "completed",
        "target_date": "2026-05-11",
        "outcome": "Calcium 9.6 mg/dL after nine weeks of treatment",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "FVC and DLCO improved by at least 10 percent of predicted within six months",
        "status": "completed",
        "target_date": "2026-08-24",
        "outcome": "FVC 74 to 90 percent and DLCO 62 to 76 percent of predicted",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lung-function goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "No myocardial FDG uptake on repeat PET after about six months of treatment, with left ventricular function stable or better",
        "status": "completed",
        "target_date": "2026-08-24",
        "outcome": "Myocardial uptake resolved; ejection fraction 54 percent from 47",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic cardiac goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "Prednisone at 10 mg a day or less by six months, with methotrexate as the steroid-sparing agent",
        "status": "completed",
        "target_date": "2026-08-24",
        "outcome": "Prednisone 10 mg at six months and tapering",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic treatment goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "GOAL-006",
        "display": "Back on stage with a schedule she can sustain, with her voice protected",
        "status": "completed",
        "target_date": "2026-08-24",
        "outcome": "Two concerts a week since late spring; a longer autumn tour planned",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic function goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Pulmonology (sarcoidosis) consultation within two weeks, with EBUS-guided lymph node sampling arranged directly from the referral, to confirm the diagnosis and plan treatment",
        "status": "completed",
        "guideline_ids": [
          "GL-ATS-SARC-2020",
          "GL-ERS-SARC-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic specialist consultation booked at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Diagnosis of suspected sarcoidosis: chest radiograph and CT of the chest, tissue by EBUS-guided needle aspiration rather than mediastinoscopy, stains and cultures for mycobacteria and fungi, an interferon-gamma release assay and HIV test to exclude other causes; serum ACE is not used to make or exclude the diagnosis",
        "status": "completed",
        "guideline_ids": [
          "GL-ATS-SARC-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic diagnostic plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Screening every patient with suspected sarcoidosis for other organ involvement: ECG, serum calcium with 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, creatinine, liver tests and alkaline phosphatase, complete blood count, TSH, and an eye examination; stop the calcium and vitamin D supplement while calcium is high",
        "status": "completed",
        "guideline_ids": [
          "GL-ATS-SARC-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic screening plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Cardiac evaluation for suspected cardiac sarcoidosis (abnormal ECG and palpitations): 24-hour Holter monitoring, echocardiogram, cardiac MRI with late gadolinium enhancement, and cardiac FDG-PET with a dietary preparation, all before glucocorticoids begin; cardiology and electrophysiology review",
        "status": "completed",
        "guideline_ids": [
          "GL-HRS-CS-2014",
          "GL-AHA-CS-2024",
          "GL-ATS-SARC-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic cardiac plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        },
        "recorded_date": "2026-02-23"
      },
      {
        "id": "INT-005",
        "display": "Treatment of cardiac and pulmonary sarcoidosis: prednisone 40 mg daily, tapered over about six months toward 5 to 10 mg, with methotrexate 15 mg weekly (increased to 20 mg) and folic acid, continued for at least a year for cardiac disease; repeat FDG-PET after about six months",
        "status": "completed",
        "guideline_ids": [
          "GL-ERS-SARC-2021",
          "GL-AHA-CS-2024",
          "GL-HRS-CS-2014"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic treatment decided when cardiac involvement was confirmed.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        },
        "recorded_date": "2026-03-09"
      },
      {
        "id": "INT-006",
        "display": "Methotrexate safety: hepatitis B and C screening before starting, blood count, liver tests and creatinine every two to four weeks for the first three months and then every eight to twelve weeks, no alcohol, and no trimethoprim-sulfamethoxazole while on methotrexate",
        "status": "completed",
        "guideline_ids": [
          "GL-ACR-DMARD-2012",
          "GL-ERS-SARC-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic methotrexate monitoring decided at the start of treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        },
        "recorded_date": "2026-03-09"
      },
      {
        "id": "INT-007",
        "display": "Glucocorticoid protection: bone density scan and FRAX, alendronate weekly, dietary calcium only (no supplements while calcium was high), vitamin D replaced cautiously once calcium is normal, with calcium rechecked; atovaquone pneumocystis prophylaxis while prednisone is 20 mg or more with methotrexate; glucose, blood pressure, weight, mood, sleep and eye pressure checks",
        "status": "completed",
        "guideline_ids": [
          "GL-ACR-GIOP-2022",
          "GL-CMID-2026",
          "GL-ERS-SARC-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic protection plan decided at the start of treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        },
        "recorded_date": "2026-03-09"
      },
      {
        "id": "INT-008",
        "display": "Vaccination before immunosuppression: PCV20, recombinant zoster vaccine, hepatitis B vaccine for a non-immune adult, influenza and COVID-19 vaccines; no live vaccines while on prednisone and methotrexate",
        "status": "completed",
        "guideline_ids": [
          "GL-CDC-IMZ-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic vaccination plan decided at the start of treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        },
        "recorded_date": "2026-03-09"
      },
      {
        "id": "INT-009",
        "display": "Arrhythmia risk: metoprolol for ventricular ectopy; electrophysiology study for a left ventricular ejection fraction above 35 percent with scar on MRI and nonsustained ventricular tachycardia, and a dual-chamber defibrillator if sustained ventricular tachycardia is induced; remote device monitoring, including on tour",
        "status": "completed",
        "guideline_ids": [
          "GL-HRS-CS-2014",
          "GL-AHA-CS-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic arrhythmia plan decided when cardiac involvement was confirmed.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        },
        "recorded_date": "2026-03-09"
      },
      {
        "id": "INT-010",
        "display": "Performing and travel: concerts paused until the defibrillator wound has healed and the first device check is done, then a lighter schedule with rest days, voice care, and a travel letter with her device card and medicine list; no driving for one week after the implant",
        "status": "completed",
        "guideline_ids": [
          "GL-HRS-CS-2014",
          "GL-ERS-SARC-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0012",
            "CLM-0002",
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic plan for her work decided with her when treatment began.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        },
        "recorded_date": "2026-03-09"
      },
      {
        "id": "INT-011",
        "display": "Depression screening at each phase, plain explanations with written information, and support she chooses; she decides who receives each note",
        "status": "completed",
        "guideline_ids": [
          "GL-USPSTF-DEP-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic psychosocial plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T22:30:00-05:00"
        }
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-ATS-SARC-2020",
        "title": "Crouser ED, et al. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 2020;201(8):e26-e51 (PMID 32293205)",
        "publisher": "American Thoracic Society",
        "url": "https://pubmed.ncbi.nlm.nih.gov/32293205/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-ERS-SARC-2021",
        "title": "Baughman RP, et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J 2021;58(6):2004079 (PMID 34140301)",
        "publisher": "European Respiratory Society",
        "url": "https://pubmed.ncbi.nlm.nih.gov/34140301/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-HRS-CS-2014",
        "title": "Birnie DH, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014;11(7):1305-1323 (PMID 24819193)",
        "publisher": "Heart Rhythm Society",
        "url": "https://pubmed.ncbi.nlm.nih.gov/24819193/",
        "version_or_year": "2014"
      },
      {
        "guideline_id": "GL-AHA-CS-2024",
        "title": "Cheng RK, et al. Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association. Circulation 2024;149(21):e1197-e1216 (PMID 38634276)",
        "publisher": "American Heart Association",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38634276/",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-ACR-GIOP-2022",
        "title": "Humphrey MB, et al. 2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Rheumatol 2023;75(12):2088-2102 (PMID 37845798)",
        "publisher": "American College of Rheumatology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/37845798/",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-ACR-DMARD-2012",
        "title": "Singh JA, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res 2012;64(5):625-639 (PMID 22473917) (methotrexate laboratory monitoring)",
        "publisher": "American College of Rheumatology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/22473917/",
        "version_or_year": "2012"
      },
      {
        "guideline_id": "GL-BAUGHMAN-2016",
        "title": "Baughman RP, et al. Sarcoidosis in America. Analysis Based on Health Care Use. Ann Am Thorac Soc 2016;13(8):1244-1252 (PMID 27509154)",
        "publisher": "Annals of the American Thoracic Society",
        "url": "https://pubmed.ncbi.nlm.nih.gov/27509154/",
        "version_or_year": "2016"
      },
      {
        "guideline_id": "GL-MIRSAEIDI-2015",
        "title": "Mirsaeidi M, et al. Racial difference in sarcoidosis mortality in the United States. Chest 2015;147(2):438-449 (PMID 25188873)",
        "publisher": "CHEST",
        "url": "https://pubmed.ncbi.nlm.nih.gov/25188873/",
        "version_or_year": "2015"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Medical Condition and Other Indication",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, osteoporosis monograph",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-AAO-HNS-HOARSE-2018",
        "title": "Stachler RJ, et al. Clinical Practice Guideline: Hoarseness (Dysphonia) (Update). Otolaryngol Head Neck Surg 2018;158(1_suppl):S1-S42 (PMID 29494321)",
        "publisher": "American Academy of Otolaryngology-Head and Neck Surgery Foundation",
        "url": "https://pubmed.ncbi.nlm.nih.gov/29494321/",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-BREAST-2024",
        "title": "Breast Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-USPSTF-CRC-2021",
        "title": "Colorectal Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-CERV-2018",
        "title": "Cervical Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-DM-2021",
        "title": "Prediabetes and Type 2 Diabetes: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-for-prediabetes-and-type-2-diabetes",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-STATIN-2022",
        "title": "Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-USPSTF-IPV-2018",
        "title": "Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening",
        "version_or_year": "2018"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the diagnosis by EBUS with infection excluded, the decision to complete cardiac MRI and FDG-PET before glucocorticoids, the prednisone dose and taper with methotrexate, the defibrillator decision after an inducible electrophysiology study with an ejection fraction of 47 percent, the handling of calcium and vitamin D with alendronate, atovaquone instead of trimethoprim-sulfamethoxazole with methotrexate, and the touring plan."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "She died in 1972; the recent-death rule does not apply. Claims rest on The New York Times obituary, the presidential statement, PBS, Biography.com, New Orleans Historical, TheWrap and Wikipedia's summary of Goreau's biography. The cause of death and the cardiac sarcoidosis interpretation are R; everything clinical is synthetic."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "No mental health or substance claim is made; mood screens are synthetic and below the threshold for a safety assessment. Weight is recorded as measured, without comment on her body. Her death is recorded once, without detail. No relative, spouse, colleague or historical physician is given a role in the modern episode."
    }
  }
}
